Datadog (DDOG) 10-K 23 Feb 24 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Feb. 15, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-39051
Entity Registrant Name	Datadog, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-2825503
Entity Address, Address Line One	620 8th Avenue,
Entity Address, Address Line Two	45th Floor
Entity Address, City or Town	New York,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	866
Local Phone Number	329-4466
Title of 12(b) Security	Class A common stock, par value $0.00001 per share
Trading Symbol	DDOG
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 29,300
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for its 2024 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2023.
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Central Index Key	0001561550
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		305,929,910
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		25,944,197

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2023
Auditor Information [Abstract]
Auditor Name	Deloitte & Touche LLP
Auditor Location	New York, New York
Auditor Firm ID	34

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 330,339	$ 338,985
Marketable securities	2,252,559	1,545,341
Accounts receivable, net of allowance for credit losses of $12,096 and $5,626 as of December 31, 2023 and 2022, respectively	509,279	399,551
Deferred contract costs, current	44,938	33,054
Prepaid expenses and other current assets	41,022	27,303
Total current assets	3,178,137	2,344,234
Property and equipment, net	171,872	125,346
Operating lease assets	126,562	87,629
Goodwill	352,694	348,277
Intangible assets, net	9,617	16,365
Deferred contract costs, non-current	73,728	55,338
Restricted cash	0	3,303
Other assets	23,462	24,360
TOTAL ASSETS	3,936,072	3,004,852
CURRENT LIABILITIES:
Accounts payable	87,712	23,474
Accrued expenses and other current liabilities	127,631	171,158
Operating lease liabilities, current	21,974	22,092
Deferred revenue, current	765,735	543,024
Total current liabilities	1,003,052	759,748
Operating lease liabilities, non-current	138,128	76,582
Convertible senior notes, net	742,235	738,847
Deferred revenue, non-current	21,210	12,944
Other liabilities	6,093	6,226
Total liabilities	1,910,718	1,594,347
COMMITMENTS AND CONTINGENCIES (NOTE 9)
STOCKHOLDERS' EQUITY:
Additional paid-in capital	2,181,267	1,625,190
Accumulated other comprehensive loss	(2,218)	(12,422)
Accumulated deficit	(153,698)	(202,266)
Total stockholders’ equity	2,025,354	1,410,505
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	3,936,072	3,004,852
Class A Common Stock
STOCKHOLDERS' EQUITY:
Common stock, value	3	3
Class B Common Stock
STOCKHOLDERS' EQUITY:
Common stock, value	$ 0	$ 0

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accounts receivable, allowance for credit losses	$ 12,096	$ 5,626
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, issued (in shares)	305,395,175	293,573,825
Common stock, outstanding (in shares)	305,395,175	293,573,825
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	310,000,000	310,000,000
Common stock, issued (in shares)	25,684,571	25,616,018
Common stock, outstanding (in shares)	25,684,571	25,616,018

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 2,128,359	$ 1,675,100	$ 1,028,784
Cost of revenue	409,908	346,743	234,245
Gross profit	1,718,451	1,328,357	794,539
Operating expenses:
Research and development	962,447	752,351	419,769
Sales and marketing	609,276	495,288	299,497
General and administrative	180,192	139,413	94,429
Total operating expenses	1,751,915	1,387,052	813,695
Operating loss	(33,464)	(58,695)	(19,156)
Other income:
Interest expense	(6,302)	(16,535)	(21,052)
Interest income and other income, net	100,001	37,160	21,786
Other income, net	93,699	20,625	734
Income (loss) before provision for income taxes	60,235	(38,070)	(18,422)
Provision for income taxes	11,667	12,090	2,323
Net income (loss)	48,568	(50,160)	(20,745)
Net income (loss) attributable to common stockholders, basic	48,568	(50,160)	(20,745)
Net income (loss) attributable to common stockholders, diluted	$ 48,568	$ (50,160)	$ (20,745)
Basic net income (loss) per share (in dollars per share)	$ 0.15	$ (0.16)	$ (0.07)
Diluted net income (loss) per share (in dollars per share)	$ 0.14	$ (0.16)	$ (0.07)
Weighted average shares used in calculating basic net income (loss) per share (in shares)	324,033	315,410	309,048
Weighted average shares used in calculating diluted net income (loss) per share (in shares)	350,292	315,410	309,048

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 48,568	$ (50,160)	$ (20,745)
Other comprehensive income (loss):
Foreign currency translation adjustments	1,050	(1,322)	(1,853)
Unrealized gain (loss) on available-for-sale marketable securities	9,154	(7,270)	(4,264)
Other comprehensive income (loss)	10,204	(8,592)	(6,117)
Comprehensive income (loss)	$ 58,772	$ (58,752)	$ (26,862)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Class A and Class B Common Stock	Class A and Class B Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2020				305,880,063	305,880,063
Beginning balance at Dec. 31, 2020	$ 957,432	$ (156,268)	$ 801,164	$ 3	$ 3	$ 1,103,305	$ (173,070)	$ 930,235	$ 2,287	$ 2,287	$ (148,163)	$ 16,802	$ (131,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				5,109,688
Issuance of common stock upon exercise of stock options	14,941					14,941
Vesting of early exercised stock options	566					566
Vesting of restricted and performance stock units (in shares)				1,483,639
Issuance (retirement) of restricted shares of common stock from acquisitions (in shares)				600,176
Issuance (retirement) of restricted shares of common stock from acquisitions	57,720					57,720
Issuance of common stock under the Employee Stock Purchase Plan (in shares)				291,871
Issuance of common stock under the Employee Stock Purchase Plan	20,278					20,278
Stock-based compensation	173,397					173,397
Change in accumulated other comprehensive loss	(6,117)								(6,117)
Net income (loss)	(20,745)										(20,745)
Ending balance (in shares) at Dec. 31, 2021				313,365,437
Ending balance at Dec. 31, 2021	1,041,203			$ 3		1,197,136			(3,830)		(152,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				2,687,334
Issuance of common stock upon exercise of stock options	9,970					9,970
Vesting of early exercised stock options	33					33
Vesting of restricted and performance stock units (in shares)				2,492,535
Issuance (retirement) of restricted shares of common stock from acquisitions (in shares)				327,662
Issuance (retirement) of restricted shares of common stock from acquisitions	14,019					14,019
Issuance of common stock under the Employee Stock Purchase Plan (in shares)				316,875
Issuance of common stock under the Employee Stock Purchase Plan	26,025					26,025
Stock-based compensation	378,007					378,007
Change in accumulated other comprehensive loss	(8,592)								(8,592)
Net income (loss)	(50,160)										(50,160)
Ending balance (in shares) at Dec. 31, 2022				319,189,843
Ending balance at Dec. 31, 2022	$ 1,410,505			$ 3		1,625,190			(12,422)		(202,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	6,455,931			6,455,931
Issuance of common stock upon exercise of stock options	$ 20,924					20,924
Vesting of restricted and performance stock units (in shares)				4,794,318
Issuance (retirement) of restricted shares of common stock from acquisitions (in shares)				122,224
Issuance (retirement) of restricted shares of common stock from acquisitions	1,886					1,886
Issuance of common stock under the Employee Stock Purchase Plan (in shares)				517,430
Issuance of common stock under the Employee Stock Purchase Plan	37,370					37,370
Stock-based compensation	495,897					495,897
Change in accumulated other comprehensive loss	10,204								10,204
Net income (loss)	48,568										48,568
Ending balance (in shares) at Dec. 31, 2023				331,079,746
Ending balance at Dec. 31, 2023	$ 2,025,354			$ 3		$ 2,181,267			$ (2,218)		$ (153,698)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 48,568	$ (50,160)	$ (20,745)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	44,465	34,629	22,938
(Accretion) amortization of (discounts) premiums on marketable securities	(41,621)	4,726	16,236
Amortization of debt discount and issuance costs	3,388	3,369	3,349
Amortization of deferred contract costs	39,207	28,003	17,866
Stock-based compensation, net of amounts capitalized	482,300	363,154	163,737
Non-cash lease expense	26,382	21,416	17,201
Allowance for credit losses on accounts receivable	11,933	5,215	2,311
Loss on disposal of property and equipment	706	1,662	274
Changes in operating assets and liabilities:
Accounts receivable, net	(121,661)	(135,701)	(107,112)
Deferred contract costs	(69,481)	(51,098)	(42,775)
Prepaid expenses and other current assets	(13,508)	(6,565)	(737)
Other assets	1,018	(5,179)	(2,627)
Accounts payable	57,773	(1,286)	3,078
Accrued expenses and other liabilities	(40,489)	37,578	37,270
Deferred revenue	230,974	168,644	176,281
Net cash provided by operating activities	659,954	418,407	286,545
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of marketable securities	(2,558,013)	(1,413,717)	(1,125,519)
Maturities of marketable securities	1,864,557	1,137,724	1,046,560
Proceeds from sale of marketable securities	36,995	2,090	67,749
Purchases of property and equipment	(27,586)	(35,261)	(9,956)
Capitalized software development costs	(34,820)	(29,628)	(26,069)
Cash paid for acquisition of businesses; net of cash acquired	(12,498)	(45,878)	(226,505)
Net cash used in investing activities	(731,365)	(384,670)	(273,740)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options	20,909	10,001	14,907
Proceeds from issuance of common stock under the employee stock purchase plan	37,370	26,025	20,278
Employee payroll taxes paid related to net share settlement under the employee stock purchase plan	0	0	(245)
Repayments of convertible senior notes	0	(3)	0
Net cash provided by financing activities	58,279	36,023	34,940
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,183	(1,935)	(1,993)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(11,949)	67,825	45,752
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period	342,288	274,463	228,711
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period	330,339	342,288	274,463
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income taxes	16,505	1,595	1,486
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued property and equipment purchases	7,046	972	1,746
Stock-based compensation included in capitalized software development costs	13,597	14,853	9,660
Vesting of early exercised options	0	33	566
Issuance of restricted shares of common stock for the acquisition of businesses	1,886	14,019	57,720
Acquisition holdback	750	8,123	5,555
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH WITHIN THE CONSOLIDATED BALANCE SHEETS TO THE AMOUNTS SHOW IN THE STATEMENTS OF CASH FLOWS ABOVE:
Cash and cash equivalents	330,339	338,985	270,973
Restricted cash	0	3,303	3,490
Total cash, cash equivalents and restricted cash	$ 330,339	$ 342,288	$ 274,463

Organization and Description of

Organization and Description of Business	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business Datadog, Inc. (“Datadog” or the “Company”) was incorporated in the State of Delaware on June 4, 2010. The Company is the observability and security platform for cloud applications. The Company’s SaaS platform integrates and automates infrastructure monitoring, application performance monitoring, log management, user experience monitoring, cloud security, and many other capabilities to provide unified, real-time observability and security of its customers’ entire technology stack. The Company is headquartered in New York City and has various other global office locations.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Principles of Consolidation The consolidated financial statements include the accounts of Datadog, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Segment Information The Company has a single operating and reportable segment as well as one business activity, monitoring and providing analytics on companies’ information technology (“IT”) infrastructure. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. There are no segment managers who are held accountable for operations or results below the consolidated level. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates include the fair value of marketable securities, the allowance for credit losses , the fair value of acquired assets and assumed liabilities from business combinations, useful lives of property, equipment, software, and finite lived intangibles, stock-based compensation, valuation of long-lived assets and their recoverability, including goodwill, the incremental borrowing rate for operating leases, estimated expected period of benefit for deferred contract costs, fair value of the liability component of the convertible debt, realization of deferred tax assets and uncertain tax positions, revenue recognition and the allocation of overhead costs between cost of revenue and operating expenses. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could materially differ from these estimates. Foreign Currency Translation The reporting currency of the Company is the United States dollar (“USD”). The functional currency of the Company is USD, and the functional currency of the Company’s subsidiaries is generally the local currency of the jurisdiction in which the foreign subsidiary is located. The assets and liabilities of the Company’s subsidiaries are translated to USD at exchange rates in effect at the balance sheet date. All income statement accounts are translated at monthly average exchange rates. Resulting foreign currency translation adjustments are recorded directly in accumulated other comprehensive loss as a separate component of stockholders’ equity. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income, net in the accompanying consolidated statements of operations when realized and have not been material for any of the periods presented. Revenue Recognition The Company generates revenue from the sale of subscriptions to customers using its cloud-based platform. The terms of the Company’s subscription agreements are primarily monthly, annual or multi-year. The Company’s customers can enter into (1) a subscription agreement for a committed contractual amount of usage that is apportioned ratably on a monthly basis over the term of the subscription period, (2) a subscription agreement for a committed contractual amount of usage that is delivered as used, or (3) a monthly subscription based on usage. The Company typically bills customers on an annual or multi-year subscription in advance, with any usage in excess of the committed contracted amount billed monthly in arrears. The Company typically bills customers on a monthly plan in arrears. Customers also have the option to purchase additional services priced at rates at or above the stand-alone selling price. The Company accounts for revenue contracts with customers through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation. The Company’s revenue arrangements may include infrastructure monitoring, application performance monitoring, log management, synthetics monitoring, security monitoring, continuous profiling, serverless monitoring, network monitoring, real user monitoring and incident management as well as secondary services including custom metrics in dashboard monitoring, docker container monitoring, and indexed spans. The Company has identified each service as a separate performance obligation. The transaction price is based on the fixed price for the contracted level of service plus variable consideration for additional optional purchases. Billing periods correspond to the periods over which services are performed and there are no discounts given on the purchase of future services. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on a range of actual prices charged to customers. Revenue is recognized when control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. The Company determined an output method, recognition over time, to be the most appropriate measure of progress because it most faithfully represents when the value of the services is simultaneously received and consumed by the customer, and control is transferred. For committed contractual amounts of usage, revenue is recognized ratably over the term of the subscription agreement generally beginning on the date that the platform is made available to a customer. For committed contractual amount of usage that is delivered as used, a monthly subscription based on usage, or usage in excess of a ratable subscription, the Company recognizes revenue as the product is used. Subscription revenue excludes sales and other indirect taxes. The Company applied the practical expedient in Topic 606 and did not evaluate contracts of one year or less for the existence of a significant financing component. Deferred Revenue and Remaining Performance Obligations Certain of the Company’s customers pay in advance of satisfaction of performance obligations and other customers with monthly contract terms are billed in arrears on a monthly basis. The Company records contract liabilities to deferred revenue when customers are billed or when the Company receives customer payments in advance of the performance obligations being satisfied on the Company’s contracts. Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligations include deferred revenue, multi-year contracts with future installment payments and certain unfulfilled orders against accepted customer contracts at the end of any given period. Convertible Senior Notes In accounting for the issuance of the Company’s convertible senior notes (the “2025 Notes”), the 2025 Notes were separated into liability and equity components through December 31, 2020. The carrying amounts of the liability component was calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the respective 2025 Notes. This difference represents the debt discount that is amortized to interest expense over the contractual terms of the 2025 Notes using the effective interest rate method. The equity component was recorded in additional paid-in capital. In accounting for the debt issuance costs related to the 2025 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2025 Notes in the same proportion as the allocation of the proceeds. Issuance costs attributable to the liability component are being amortized to interest expense over the contractual terms of the 2025 Notes. The issuance costs attributable to the equity component were netted against the equity component in additional paid-in capital. On January 1, 2021, the Company adopted ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU No. 2020-06”). As a result of the adoption, the debt conversion option of $177.2 million and debt issuance costs of $4.1 million previously attributable to the equity component are no longer presented in equity. Similarly, the debt discount, that is equal to the carrying value of the embedded conversion feature upon issuance, is no longer amortized into income as interest expense over the life of the instrument. This resulted in a $16.8 million decrease to the opening balance of accumulated deficit, a $173.1 million decrease to the opening balance of additional paid-in capital and a $156.3 million increase to the opening balance of convertible senior notes, net on the consolidated balance sheet. Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription services to paying customers, including data center and networking expenses, employee compensation (including stock-based compensation) and other employee-related expenses for customer experience and technical operations staff, payments to outside service providers, payment processing fees, amortization of capitalized internally developed software costs and acquired developed technology, and allocated overhead costs. Research and Development Costs Research and development costs are expensed as incurred. Research and development costs consist of employee compensation (including stock-based compensation) and other employee-related expenses, materials and supplies, and allocated overhead costs such as rent and facilities costs. Sales and Marketing Costs Sales and marketing costs consist primarily of personnel costs for the Company’s sales and marketing organization, including stock-based compensation and commissions, costs of general marketing and promotional activities, including the free tier and introductory trials of the Company’s products, travel-related expenses, amortization of acquired customer relationships, and allocated overhead costs. Advertising Costs Advertising costs are expensed as incurred and were approximately $21.8 million, $25.5 million and $20.8 million for the years ended December 31, 2023, 2022 and 2021, respectively, and are included in sales and marketing expense in the accompanying consolidated statement of operations. Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts for financial reporting and the tax bases of assets and liabilities. The deferred assets and liabilities are recorded at the statutorily enacted tax rates anticipated to be in effect when such temporary differences reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established; when based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company engages in transactions in which the tax consequences may be subject to uncertainty. The Company accounts for uncertain tax positions based on an evaluation as to whether it is more likely than not that a tax position will be sustained on audit, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the appropriate tax authorities have full knowledge of all relevant information concerning the tax position. The Company accounts for uncertain tax positions as non-current tax liabilities or through a reduction of a corresponding deferred tax asset. The tax benefit recognized is based on the largest amount that is greater than 50% likely of being realized upon ultimate settlement. The Company includes potential interest expense and penalties related to its uncertain tax positions in income tax expense. Stock-Based Compensation The Company recognizes and measures compensation expense for all stock-based payment awards granted to employees, directors, and nonemployees, including stock options, restricted stock units (“RSUs”), performance-based awards (“PSUs”), and the employee stock purchase plan (the “ESPP”) based on the fair value of the awards on the date of grant. The fair value of each stock option granted is estimated using the Black-Scholes option pricing model. The determination of the grant date fair value using an option-pricing model is affected by the estimated fair value of the Company’s Class A common stock as well as assumptions regarding a number of other complex and subjective variables. These variables include expected stock price volatility over the expected term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate for the expected term of the award and expected dividends. The fair value of RSUs and PSUs is determined by the closing price on the date of grant of the Company’s Class A common stock, as reported on The Nasdaq Global Select Market. The Company estimates the fair value of the rights to acquire stock under the ESPP using the Black-Scholes option pricing model. Stock-based compensation for stock options and RSUs is recognized on a straight-line basis over the requisite service period and account for forfeitures as they occur. Stock-based compensation for PSUs is amortized under the accelerated attribution method and may be adjusted over the vesting period based on interim estimates of performance against pre-set objectives. PSUs will vest upon achievement of specified performance targets and subject to continuous service through the applicable vesting dates. The compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied and the Company accounts for forfeitures as they occur. The Company also has certain options that have performance-based vesting conditions; stock-based compensation expense for such awards is recognized on a straight-line basis from the time the vesting condition is likely to be met through the time the vesting condition has been achieved. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents consist of money market funds, corporate debt securities, and U.S. government treasury securities. Marketable Securities The Company’s marketable securities consist of corporate debt securities, commercial paper, certificates of deposit, U.S. government treasury securities, and U.S. government agency securities. The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable securities as available-for-sale securities as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its marketable securities within current assets on the consolidated balance sheet. Available-for-sale securities are recorded at fair value each reporting period. Premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield using the effective interest method. Interest income is recognized when earned. Unrealized gains and losses on these marketable securities are presented net of tax and reported as a separate component of accumulated other comprehensive loss until realized. Realized gains and losses are determined based on the specific identification method and are reported in Interest income and other income, net in the consolidated statements of operations. The Company periodically evaluates its marketable securities to assess whether an investment’s fair value is less than its amortized cost basis and if the decline in the fair value is attributable to a credit loss. Declines in fair value judged to be related to credit loss are reported in Interest income and other income, net in the consolidated statements of operations. Restricted Cash Restricted cash primarily consists of collateralized letters of credit established in connection with lease agreements for the Company’s facilities. Restricted cash is included in current assets for leases that expire within one year and is included in non-current assets for leases that expire in more than one year from the balance sheet date. Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk primarily consist of cash and cash equivalents, marketable securities and accounts receivable. Cash deposits may, at times, exceed amounts insured by the Federal Deposit Insurance Corporation (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”). The Company has not experienced any losses on its deposits of cash and cash equivalents to date. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying consolidated balance sheets. Geographical Information - Long-Lived Assets As of December 31, 2023, and 2022, 67% and 66% of the Company’s long-lived assets were located in the United States and 33% and 34% were located outside of the United States, primarily in EMEA, respectively. Fair Value of Financial Instruments The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. The Company’s financial instruments consist of cash equivalents, marketable securities, accounts receivable, accounts payable and accrued expenses. Cash equivalents are stated at amortized cost, which approximates fair value at the balance sheet dates, due to the short period of time to maturity. Marketable securities are recorded at fair value. Accounts receivable, accounts payable, and accrued expenses are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Accounts Receivable and Allowance for Credit Losses Accounts receivable includes billed and unbilled receivables. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for credit losses by considering the age of each outstanding invoice and the collection history to determine the appropriate amount of allowance for credit losses. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified. Unbilled accounts receivable represents revenue recognized on contracts for which billings have not yet been presented to customers because the amounts were earned but not contractually billable as of the balance sheet date, substantially all of which is expected to be billed and collected within one year. Internal-Use Software Development Costs The Company capitalizes qualifying internal-use software development costs related to its cloud platform. The costs consist of personnel costs (including related benefits and stock-based compensation) that are incurred during the application development stage. Capitalization of costs begins when two criteria are met: (1) the preliminary project stage is completed, and (2) it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post implementation operating activities are expensed as incurred. Capitalized costs are included in property and equipment. These costs are amortized over the estimated useful life of the software, which is two years, on a straight-line basis, which represents the manner in which the expected benefit will be derived. The amortization of costs related to the platform applications is included in cost of revenue and sales and marketing expense based on an allocation between paid customer accounts and free customer accounts not generating revenue. Property and Equipment, Net Property and equipment, net is stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful life of the related asset. Expenses that improve an asset or extend its remaining useful life are capitalized. Costs of maintenance or repairs that do not extend the lives of the respective assets are charged to expenses as incurred. Deferred Contract Costs Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. There are no sales commissions earned on renewals . These costs are deferred and then amortized over a period of benefit which is determined to be 4 years. The Company determined the period of benefit by taking into consideration the length of terms in its customer contracts, life of the technology and other factors . Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current; the remaining portion is recorded as deferred contract costs, non-current, in the consolidated balance sheets. Deferred contract costs are periodically analyzed for impairment. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of operations. Business Combinations When the Company acquires a business, the purchase consideration is allocated to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated respective fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require the Company to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired users, acquired technology, and trade names from a market participant perspective, useful lives and discount rates. The Company’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to other income, net in the consolidated statement of operations. Accounting for Impairment of Long-Lived Assets (Including Goodwill and Intangibles) Long-lived assets with finite lives include property and equipment, capitalized development software costs and acquired intangible assets. Long-lived assets are amortized over their estimated useful lives which are as follows: Computers and equipment 3 years Furniture and fixtures 5 years Leasehold improvements Shorter of lease term or useful life of asset Capitalized software development costs 2 years Developed technology 3 years Customer relationships 4 years The Company evaluates long lived assets, including acquired intangible assets and capitalized software development costs, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or the estimated useful life becomes shorter than originally estimated. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset exceeds these estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group, based on discounted cash flows. Goodwill is not amortized but rather tested for impairment at least annually on October 1, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. Goodwill impairment is recognized when the quantitative assessment results in the carrying value exceeding the fair value, in which case an impairment charge is recorded to the extent the carrying value exceeds the fair value. The Company did not recognize any impairment of goodwill during the years ended December 31, 2023, 2022 or 2021. Operating Leases The Company determines if an arrangement is a lease at inception. Operating lease assets and liabilities are reflected within operating lease assets, operating lease liabilities, current, and operating lease liabilities, non-current, on the consolidated balance sheets. For short-term leases (an initial term of 12 months or less), an operating lease asset and corresponding lease liability are not recorded and the Company records rent expense in its consolidated statements of operations on a straight-line basis over the lease term. Operating lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease assets also include any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately. Net Income (Loss) Per Share Attributable to Common Stockholders Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of Class A common stock and Class B common stock (together “common stock ” ) outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period giving effect to all potentially dilutive securities to the extent they are dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net income (loss) per share by application of the two-class method. During the periods when the Company is in a net loss position, the net loss attributable to common stockholders was not allocated to the unvested common stock under the two-class method as these securities do not have a contractual obligation to share in the Company’s losses. Accounting Pronouncements Recently Adopted In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ( “ ASU No. 2021-08”), which intends to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. It is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company early adopted ASU No. 2021-08 on January 1, 2022 on a prospective basis with no material impact on the Company's consolidated financial statements. Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07 , Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU No. 2023-07 ” ), which intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09 , Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU No. 2023-09 ” ), which intends to increase the transparency of income tax disclosures, particularly the rate reconciliation table and disclosures about income taxes paid. For public business entities, it is effective for annual periods beginning after December 15, 2024, and interim periods beginning after December 15, 2025, with early adoption permitted. The Company has not early adopted ASU No. 2023-09 as of December 31, 2023 and is evaluating its impact.

Marketable Securities

Marketable Securities	12 Months Ended
	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents on the consolidated balance sheet as of December 31, 2023 and December 31, 2022 (in thousands): December 31, 2023 Amortized Unrealized Unrealized Fair Corporate debt securities $ 776,323 $ 770 $ (1,140) $ 775,953 Commercial paper 605,291 570 (75) 605,786 U.S. government treasury securities 460,854 390 (1,399) 459,845 Certificates of deposit 264,405 335 (15) 264,725 U.S. government agency securities 146,611 — (361) 146,250 Marketable securities $ 2,253,484 $ 2,065 $ (2,990) $ 2,252,559 December 31, 2022 Amortized Unrealized Unrealized Fair Corporate debt securities $ 813,598 $ 64 $ (7,554) $ 806,108 Commercial paper 357,030 64 (821) 356,273 Certificates of deposit 174,080 37 (587) 173,530 U.S. government treasury securities 120,977 — (1,099) 119,878 U.S. government agency securities 89,718 12 (178) 89,552 Marketable securities $ 1,555,403 $ 177 $ (10,239) $ 1,545,341 Interest receivable of $15.1 million and $8.1 million is included in Prepaid expenses and other current assets on the consolidated balance sheets as of December 31, 2023 and 2022, respectively. The Company did not recognize an allowance for credit losses against interest receivable as of December 31, 2023 and 2022 because such potential losses were not material. As of December 31, 2023, the fair values of available-for-sale marketable securities, by remaining contractual maturity, were as follows (in thousands): Due within one year $ 1,799,542 Due in one year through five years 453,017 Total $ 2,252,559 The Company does not believe that any unrealized losses are attributable to credit-related factors based on its evaluation of available evidence. To determine whether a decline in value is related to credit loss, the Company evaluates, among other factors: the extent to which the fair value is less than the amortized cost basis, changes to the rating of the security by a rating agency and any adverse conditions specifically related to an issuer of a security or its industry. Unrealized gains and losses on marketable securities are presented net of tax.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value on a recurring basis as of December 31, 2023 and 2022, and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value (in thousands): Fair Value Measurement as of December 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 240,909 $ — $ — $ 240,909 Corporate debt securities — 484 — 484 U.S. government treasury securities — 53,972 — 53,972 Marketable Securities: Corporate debt securities — 775,953 — 775,953 Commercial paper — 605,786 — 605,786 Certificates of deposit — 264,725 — 264,725 U.S. government treasury securities — 459,845 — 459,845 U.S. government agency securities — 146,250 — 146,250 Total financial assets $ 240,909 $ 2,307,015 $ — $ 2,547,924 Fair Value Measurement as of December 31, 2022 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 302,902 $ — $ — $ 302,902 Corporate debt securities — 2,493 — 2,493 Marketable Securities: Corporate debt securities — 806,108 — 806,108 Commercial paper — 356,273 — 356,273 Certificates of deposit — 173,530 — 173,530 U.S. government treasury securities — 119,878 — 119,878 U.S. government agency securities — 89,552 — 89,552 Total financial assets $ 302,902 $ 1,547,834 $ — $ 1,850,736 The Company considers all highly liquid investments, including money market funds with an original maturity of three months or less at the date of purchase, to be cash equivalents. The Company uses quoted prices in active markets for assets to determine the fair value of its Level 1 investments in money market funds. The Company classifies its commercial paper, corporate debt securities, certificates of deposit, U.S. government treasury securities, and Non-U.S. government securities within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded. In addition to its cash equivalents and marketable securities, the Company measures the fair value of its outstanding convertible senior notes on a quarterly basis for disclosure purposes. The Company considers the fair value of the convertible senior notes to be a Level 2 measurement due to limited trading activity of the convertible senior notes. Refer to Note 8, Convertible Senior Notes , to the consolidated financial statements for further details.

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): December 31, December 31, Computers and equipment $ 35,736 $ 33,376 Furniture and fixtures 17,202 13,315 Leasehold improvements 55,111 27,683 Capitalized software development costs 192,691 134,890 Total property and equipment $ 300,740 $ 209,264 Less: accumulated depreciation and amortization (128,868) (83,918) Total property and equipment, net $ 171,872 $ 125,346 As discussed in Note 2, Basis of Presentation and Summary of Significant Accounting Policies —Internal-Use Software Development Costs, the Company capitalizes costs related to the development of computer software for internal-use and is included in capitalized software development costs within property and equipment, net. Depreciation and amortization expense was approximately $35.6 million, $27.0 million, and $18.5 million for the years ended December 31, 2023, 2022 and 2021, respectively.

Acquisitions, Intangible Assets

Acquisitions, Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2023
Acquisitions, Intangible Assets And Goodwill [Abstract]
Acquisitions, Intangible Assets and Goodwill	Acquisitions, Intangible Assets and Goodwill 2023 Acquisitions During the year ended December 31, 2023, the Company entered into three purchase agreements for acquisitions of businesses, each of which were accounted for as business combinations in accordance with ASC 805, Business Combinations . The Company does not consider these acquisitions to be material, individually or in aggregate. The total purchase price was allocated to intangible assets in the amount of $2.1 million and goodwill in the amount of $3.5 million based on the respective estimated fair values. The resulting goodwill from each of the agreements is not deductible for income tax purposes. Pro forma results of operations from these acquisitions have not been presented because they were not material to the consolidated results of operations. 2022 Acquisitions During the year ended December 31, 2022, the Company entered into four purchase agreements for acquisitions of businesses, each of which were accounted for as business combinations in accordance with ASC 805, Business Combinations . The Company does not consider these acquisitions to be material, individually or in aggregate. The total purchase price was allocated to intangible assets in the amount of $8.2 million and goodwill in the amount of $56.6 million based on the respective estimated fair values. The resulting goodwill from each of the agreements is not deductible for income tax purposes. Pro forma results of operations from these acquisitions have not been presented because they were not material to the consolidated results of operations. 2021 Acquisitions In October and December 2021, the Company entered into two purchase agreements for acquisitions of businesses, each of which were accounted for as business combinations in accordance with ASC 805, Business Combinations . The Company does not consider these acquisitions to be material, individually or in aggregate. The total purchase price was allocated to intangible assets in the amount of $4.3 million and goodwill in the amount of $36.6 million based on the respective estimated fair values. The resulting goodwill from both agreements is not deductible for income tax purposes. Pro forma results of operations from these acquisitions have not been presented because they were not material to the consolidated results of operations. In April 2021, the Company entered into a stock purchase agreement whereby the Company acquired all of the issued and outstanding shares of a SaaS based security platform company. The consideration was approximately $219.4 million, comprising cash and Class A common stock. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The purchase price was allocated to intangible assets in the amount of $12.0 million and goodwill in the amount of $204.3 million based on the respective estimated fair values. The resulting goodwill is not deductible for income tax purposes. Intangible assets consisted of developed technology in the amount of $8.7 million and customer relationships in the amount of $3.3 million. The useful life for developed technology and customer relationships are three In February 2021, the Company entered into a stock purchase agreement whereby the Company acquired all of the issued and outstanding shares of an observability data pipeline tool company with the purchase price paid in cash and Class A common stock. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations . The purchase price was allocated to intangible assets in the amount of $1.7 million and goodwill in the amount of $34.3 million based on the respective estimated fair values. The resulting goodwill is not deductible for income tax purposes. Pro forma results of operations for this acquisition have not been presented because they were not material to the consolidated results of operations. Intangible Assets Intangible assets, net consisted of the following (in thousands): December 31, 2023 Gross Accumulated Net Amortization Developed technology $ 24,995 $ (16,428) $ 8,567 3 years Customer relationships 3,300 (2,250) 1,050 4 years Total $ 28,295 $ (18,678) $ 9,617 December 31, 2022 Gross Accumulated Net Amortization Developed technology $ 24,460 $ (9,970) $ 14,490 3 years Customer relationships 3,300 (1,425) 1,875 4 years Total $ 27,760 $ (11,395) $ 16,365 Intangible amortization expense was approximately $8.9 million, $7.6 million and $4.4 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization of developed technology and customer relationships are included in cost of revenue and sales and marketing expense, respectively, on the Company’s consolidated statement of operations and comprehensive loss. As of December 31, 2023, future amortization expense by year is expected to be as follows (in thousands): Amount 2024 $ 6,489 2025 2,597 2026 531 Total $ 9,617 Goodwill The changes in the carrying amount of goodwill were as follows (in thousands): Amount Balance as of December 31, 2022 $ 348,277 2023 Acquisitions 3,540 Foreign currency translation adjustments 877 Balance as of December 31, 2023 $ 352,694
Acquisitions, Intangible Assets and Goodwill	Acquisitions, Intangible Assets and Goodwill 2023 Acquisitions During the year ended December 31, 2023, the Company entered into three purchase agreements for acquisitions of businesses, each of which were accounted for as business combinations in accordance with ASC 805, Business Combinations . The Company does not consider these acquisitions to be material, individually or in aggregate. The total purchase price was allocated to intangible assets in the amount of $2.1 million and goodwill in the amount of $3.5 million based on the respective estimated fair values. The resulting goodwill from each of the agreements is not deductible for income tax purposes. Pro forma results of operations from these acquisitions have not been presented because they were not material to the consolidated results of operations. 2022 Acquisitions During the year ended December 31, 2022, the Company entered into four purchase agreements for acquisitions of businesses, each of which were accounted for as business combinations in accordance with ASC 805, Business Combinations . The Company does not consider these acquisitions to be material, individually or in aggregate. The total purchase price was allocated to intangible assets in the amount of $8.2 million and goodwill in the amount of $56.6 million based on the respective estimated fair values. The resulting goodwill from each of the agreements is not deductible for income tax purposes. Pro forma results of operations from these acquisitions have not been presented because they were not material to the consolidated results of operations. 2021 Acquisitions In October and December 2021, the Company entered into two purchase agreements for acquisitions of businesses, each of which were accounted for as business combinations in accordance with ASC 805, Business Combinations . The Company does not consider these acquisitions to be material, individually or in aggregate. The total purchase price was allocated to intangible assets in the amount of $4.3 million and goodwill in the amount of $36.6 million based on the respective estimated fair values. The resulting goodwill from both agreements is not deductible for income tax purposes. Pro forma results of operations from these acquisitions have not been presented because they were not material to the consolidated results of operations. In April 2021, the Company entered into a stock purchase agreement whereby the Company acquired all of the issued and outstanding shares of a SaaS based security platform company. The consideration was approximately $219.4 million, comprising cash and Class A common stock. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The purchase price was allocated to intangible assets in the amount of $12.0 million and goodwill in the amount of $204.3 million based on the respective estimated fair values. The resulting goodwill is not deductible for income tax purposes. Intangible assets consisted of developed technology in the amount of $8.7 million and customer relationships in the amount of $3.3 million. The useful life for developed technology and customer relationships are three In February 2021, the Company entered into a stock purchase agreement whereby the Company acquired all of the issued and outstanding shares of an observability data pipeline tool company with the purchase price paid in cash and Class A common stock. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations . The purchase price was allocated to intangible assets in the amount of $1.7 million and goodwill in the amount of $34.3 million based on the respective estimated fair values. The resulting goodwill is not deductible for income tax purposes. Pro forma results of operations for this acquisition have not been presented because they were not material to the consolidated results of operations. Intangible Assets Intangible assets, net consisted of the following (in thousands): December 31, 2023 Gross Accumulated Net Amortization Developed technology $ 24,995 $ (16,428) $ 8,567 3 years Customer relationships 3,300 (2,250) 1,050 4 years Total $ 28,295 $ (18,678) $ 9,617 December 31, 2022 Gross Accumulated Net Amortization Developed technology $ 24,460 $ (9,970) $ 14,490 3 years Customer relationships 3,300 (1,425) 1,875 4 years Total $ 27,760 $ (11,395) $ 16,365 Intangible amortization expense was approximately $8.9 million, $7.6 million and $4.4 million for the years ended December 31, 2023, 2022 and 2021, respectively. Amortization of developed technology and customer relationships are included in cost of revenue and sales and marketing expense, respectively, on the Company’s consolidated statement of operations and comprehensive loss. As of December 31, 2023, future amortization expense by year is expected to be as follows (in thousands): Amount 2024 $ 6,489 2025 2,597 2026 531 Total $ 9,617 Goodwill The changes in the carrying amount of goodwill were as follows (in thousands): Amount Balance as of December 31, 2022 $ 348,277 2023 Acquisitions 3,540 Foreign currency translation adjustments 877 Balance as of December 31, 2023 $ 352,694

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): December 31, December 31, Accrued cloud hosting and infrastructure expenses (1) $ 13,783 $ 73,566 Accrued compensation and commissions 61,541 46,736 Other tax liability and sales tax 30,775 25,818 Other accrued expenses 21,532 25,038 Total accrued expenses and other current liabilities $ 127,631 $ 171,158 _____________________ 1) Due to the timing of when invoices are received, accounts payable on the consolidated balance sheets includes cloud hosting and infrastructure expenses of $70.2 million and $12.6 million for the years ended December 31, 2023 and 2022, respectively.

Convertible Senior Notes

Convertible Senior Notes	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 2, 2020, the Company issued $747.5 million aggregate principal amount of 0.125% convertible senior notes due 2025 (the “2025 Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Securities Act”). The total net proceeds from the sale of the 2025 Notes, after deducting the initial purchasers’ discounts and debt issuance costs, were approximately $730.2 million. The 2025 Notes bear interest at a rate of 0.125% per year, payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The 2025 Notes will mature on June 15, 2025, unless earlier converted, redeemed or repurchased. Holders may convert their notes at their option at any time prior to the close of business on the business day immediately preceding March 15, 2025 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s Class A common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of 2025 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s Class A common stock and the conversion rate on each such trading day; (3) if the Company calls such 2025 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events, as set forth in the indenture governing the 2025 Notes (“the Indenture”). On or after March 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their notes, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. The conversion rate for the 2025 Notes is initially 10.8338 shares of Class A common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $92.30 per share of Class A common stock), subject to adjustment as set forth in the Indenture. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of Class A common stock or a combination of cash and shares of Class A common stock, at the Company’s election. If the Company satisfies its conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of Class A common stock, the amount of cash and shares of Class A common stock, if any, due upon conversion will be based on a daily conversion value calculated on a proportionate basis for each trading day in a 30 trading day observation period as described in the Indenture. In addition, if specific corporate events occur prior to the applicable maturity date, or if the Company elects to redeem the 2025 Notes, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event or redemption in certain circumstances. During the three months ended December 31, 2023, the conditional conversion feature of the 2025 Notes was not triggered as the last reported sale price of the Company’s Class A common stock was not greater than or equal to 130% of the conversion price for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the quarter ended December 31, 2023. Therefore the 2025 Notes are not convertible, in whole or in part, at the option of the holders between January 1, 2024 through March 31, 2024. Whether the 2025 Notes will be convertible in future periods will depend on the continued satisfaction of this condition or another conversion condition. When a conversion notice is received, the Company has the option to pay or deliver cash, shares of the Company’s common stock, or a combination thereof. Since the issuance of the 2025 Notes, the Company received and settled an immaterial amount of conversion notices from the holders in cash. As of December 31, 2023, the 2025 Notes were classified as long-term debt on the Company's consolidated balance sheet. The Company may redeem for cash all or any portion of the 2025 Notes prior to the 31st scheduled trading day immediately preceding the maturity date, at its option, if the last reported sale price of its Class A common stock was at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption at a redemption price equal to 100% of the principal amount of the 2025 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. In accounting for the issuance of the 2025 Notes, the 2025 Notes were separated into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the respective 2025 Notes. This difference represents the debt discount that is amortized to interest expense over the contractual terms of the 2025 Notes using the effective interest rate method. The carrying amount of the equity component representing the conversion option was $177.2 million. The equity component was recorded in additional paid-in capital and is not remeasured as long as it continues to meet the conditions for equity classification. In accounting for the debt issuance costs of $17.3 million related to the 2025 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2025 Notes in the same proportion as the allocation of the proceeds. Issuance costs attributable to the liability component were $13.2 million and will be amortized, along with the debt discount, to interest expense over the contractual term of the 2025 Notes at an effective interest rate of 5.97%. Issuance costs attributable to the equity component were $4.1 million and are netted against the equity component in additional paid-in capital. On January 1, 2021 the Company adopted ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity . As a result of the adoption, the debt conversion option of $177.2 million and debt issuance costs of $4.1 million previously attributable to the equity component are no longer presented in equity. Similarly, the debt discount, that is equal to the carrying value of the embedded conversion feature upon issuance, is no longer amortized into income as interest expense over the life of the instrument. This resulted in a $16.8 million decrease to the opening balance of accumulated deficit, a $173.1 million decrease to the opening balance of additional paid-in capital and a $156.3 million increase to the opening balance of convertible senior notes, net on the consolidated balance sheet. The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands): December 31, December 31, Convertible senior notes, net: Principal $ 747,496 $ 747,496 Unamortized debt issuance costs (5,261) (8,649) Net carrying amount $ 742,235 $ 738,847 As of December 31, 2023, the total estimated fair value of the 2025 Notes was approximately $1,050.2 million. The fair value was determined based on the closing trading price or quoted market price per $100 of the 2025 Notes as of the last day of trading for the period. The fair value of the 2025 Notes is primarily affected by the trading price of the Company’s Class A common stock and market interest rates. The following table sets forth the interest expense related to the 2025 Notes for the years ended December 31, 2023, 2022, and 2021 (in thousands): Year Ended December 31, 2023 2022 2021 Contractual interest expense $ 934 $ 934 $ 934 Amortization of issuance costs 3,388 3,369 3,349 Total $ 4,322 $ 4,303 $ 4,283 Capped Calls In connection with the pricing of the 2025 Notes, the Company entered into privately negotiated capped call transactions with certain counterparties (“Capped Calls”). The Capped Calls each have an initial strike price of approximately $92.30 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2025 Notes. The Capped Calls have initial cap prices of $151.04 per share, subject to certain adjustments. The Capped Calls are expected to partially offset the potential dilution to the Company’s Class A common stock upon any conversion of the 2025 Notes, with such offset subject to a cap based on the cap price. The Capped Calls cover, subject to anti-dilution adjustments, approximately 8.1 million shares of the Company’s Class A common stock. For accounting purposes, the Capped Calls are separate transactions, and not part of the 2025 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders' equity and are not accounted for as derivatives. The cost of $89.6 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital and will not be remeasured.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company enters into non-cancelable purchase commitments and operating leases in the normal course of business. Non-cancelable purchase commitments for business operations and operating lease obligations total $485.0 million and $347.1 million, respectively, as of December 31, 2023, due primarily over the next 5 years. Purchase commitments for business operations are primarily related to cloud hosting and other software-based services. The Company also issued long-term debt to finance the business. The principal and future interest payments related to the 2025 Notes are $749.0 million. 401(k) Plan —The Company sponsors a 401(k) defined contribution plan covering all eligible U.S. employees. The Company is responsible for administrative costs of the 401(k) plan and beginning on January 1, 2022, the Company began making matching contributions to the 401(k) plan. For the years ended December 31, 2023 and 2022 , the Company incurred expense of $6.3 million and $5.7 million for matching contributions, respectively. The Company did not make any matching contributions to the 401(k) plan for the year ended December 31, 2021. Legal Matters —The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. While it is not feasible to predict or determine the ultimate outcome of these matters, the Company believes that none of its current legal proceedings will have a material adverse effect on its financial position or results of operations. Indemnification —The Company enters into indemnification provisions under some agreements with other parties in the ordinary course of business, including business partners, investors, contractors, customers, and the Company’s officers, directors and certain employees. The Company has agreed to indemnify and defend the indemnified party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claim because of the Company’s activities or non-compliance with certain representations and warranties made by the Company. It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances involved in each particular provision. To date, losses recorded in the Company’s consolidated statements of operations in connection with the indemnification provisions have not been material.

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Leases	Leases The Company has entered into various non-cancelable operating leases for its facilities expiring between 2024 and 2033. Certain lease agreements contain an option for the Company to renew a lease for a term of up to three years or an option to terminate a lease early within one year. The Company considers these options, which may be elected at the Company’s sole discretion, in determining the lease term on a lease-by-lease basis. Lease expense for these leases is recognized on a straight-line basis over the lease term, with variable lease payments recognized in the period those payments are incurred. Rent expense for the years ended December 31, 2023, 2022 and 2021 was $43.5 million, $34.0 million, and $23.8 million, respectively. The Company recorded $0.9 million, $1.0 million, and $1.0 million in sub-lease income for the years ended December 31, 2023, 2022 and 2021, respectively. Sub-lease income is recorded as a credit to rent expense. The components of lease cost recognized within the Company’s consolidated statements of operations were as follows (in thousands): Year Ended December 31, 2023 2022 2021 Operating lease cost (1) $ 34,670 $ 25,212 $ 20,198 Short-term lease cost 8,797 8,739 3,609 _____________________ 1) Includes non-cash lease expense of $26.4 million, $21.4 million, and $17.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Supplemental cash flow information and non-cash activity related to the Company’s operating leases are as follows (in thousands): Year Ended December 31, 2023 2022 2021 Cash paid for amounts included in measurement of lease liabilities $ 13,273 $ 24,752 $ 20,741 Operating lease assets obtained in exchange for new lease liabilities 61,594 48,404 17,476 Maturities of lease liabilities by fiscal year for the Company’s operating leases are as follows (in thousands): Amount 2024 $ 17,995 2025 34,234 2026 31,050 2027 27,747 2028 24,479 Thereafter 73,102 Total lease payments $ 208,607 Less: imputed interest (48,505) Present value of lease liabilities $ 160,102 As of December 31, 2023, the Company had various operating leases that had not yet commenced, which are excluded from the table above. The operating leases will commence between fiscal year 2024 and 2025 with total undiscounted future payments of $138.5 million and a weighted-average lease term of 9 years. Weighted average remaining lease term and discount rate for the Company’s operating leases are as follows: December 31, December 31, Weighted average remaining lease term (years) 6.7 6.2 Weighted average discount rate 6.00% 5.12%

Revenue

Revenue	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Geographical Information Revenue by location is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Year Ended December 31, 2023 2022 2021 North America (1) $ 1,487,319 $ 1,200,719 $ 736,218 International 641,040 474,381 292,566 Total $ 2,128,359 $ 1,675,100 $ 1,028,784 1) Includes revenue from the United States of $1,411.0 million, $1,134.1 million, and $691.8 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other than the United States, no other individual country accounted for 10% or more of total revenue for the years ended December 31, 2023, 2022, or 2021. Accounts Receivable As of December 31, 2023 and 2022, unbilled accounts receivable of approximately $61.2 million and $60.0 million, respectively, was included in accounts receivable on the Company’s consolidated balance sheets. During the years ended December 31, 2023 and 2022, the Company charged $5.5 million and $2.7 million, respectively, of accounts receivable deemed uncollectible against the allowance for credit losses. Deferred Revenue and Remaining Performance Obligations Revenue recognized during the years ended December 31, 2023, 2022 and 2021 which was included in the deferred revenue balances at the beginning of each respective period, was $525.5 million, $374.6 million, and $206.6 million. As of December 31, 2023, and 2022, the aggregate transaction price allocated to remaining performance obligations was $1,839.4 million and $1,057.2 million, respectively. There is uncertainty in the timing of revenues associated with the Company’s drawdown contracts, as future revenue can often vary significantly from past revenue. However, the Company expects to recognize substantially all of the remaining performance obligations over the next 24 months. Deferred Contract Costs Deferred contract costs on the Company’s consolidated balance sheets were $118.7 million and $88.4 million as of December 31, 2023 and 2022, respectively. Amortization expense was $39.2 million, $28.0 million and $17.9 million for the years ended December 31, 2023, 2022 and 2021, respectively.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Class A and Class B Common Stock The Company has two classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Shares of Class B common stock may be converted into Class A common stock at any time at the option of the stockholder and are automatically converted to Class A common stock upon sale or transfer, subject to certain limited exceptions. During the year ended December 31, 2023, 2,016,413 shares of Class B common stock were converted into Class A common stock. As of December 31, 2023, the Company had authorized 2,000,000,000 shares of Class A common stock and 310,000,000 shares of Class B common stock, each at a par value per share of $0.00001, of which 305,395,175 shares of Class A common stock and 25,684,571 shares of Class B common stock were issued and outstanding. As of December 31, 2023 and 2022, the Company had reserved shares of common stock for future issuance as follows: December 31, 2023 2022 Options, RSUs and PSUs outstanding 25,741,136 30,930,540 Shares available for future grants 73,189,660 63,291,013 Shares subject to the employee stock purchase plan 17,481,059 14,806,591 Total shares of common stock reserved for future issuance 116,411,855 109,028,144 Equity Incentive Plans The Company has two equity incentive plans, the 2012 Equity Incentive Plan (the “2012 Plan”) and the 2019 Equity Incentive Plan (the “2019 Plan”). In connection with the Company's initial public offering (“the IPO”), the Company ceased granting awards under the 2012 Plan, and all shares that remained available for issuance under the 2012 Plan at that time were transferred to the 2019 Plan . Additionally, as of December 31, 2023, there were 12,054,709 shares of Class A common stock issuable upon conversion of Class B common stock underlying options outstanding under the 2012 Plan. Under the 2019 Plan , the Board and any other committee or subcommittee of the Board may grant stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”), and performance stock units (“PSUs”) and other awards, each equity award valued or based on the Company’s Class A common stock, to employees, directors, consultants, and advisors of the Company. As of December 31, 2023, there were 73,189,660 shares available for grant under the 2019 Plan. Stock Options The following table summarizes the Company's stock option activity and weighted-average exercise prices: Number of Weighted- Weighted- Aggregate Balance—December 31, 2022 18,551,857 $ 3.24 4.4 $ 1,303,464 Options granted — — Options exercised (6,455,931) 3.24 Options forfeited or expired (18,291) 5.50 Balance—December 31, 2023 12,077,635 $ 3.24 3.4 $ 1,426,912 Exercisable—December 31, 2023 12,074,409 $ 3.23 3.4 $ 1,426,607 As of December 31, 2023, there were 22,926 shares of Class A common stock and 12,054,709 shares of Class B common stock issuable upon the exercise of options outstanding. As of December 31, 2022, there were 28,557 shares of Class A common stock and 18,523,300 shares of Class B common stock issuable upon the exercise of options outstanding. Approximately all compensation cost related to unvested awards was recognized as of December 31, 2023. Compensation cost related to unvested awards not yet recognized was approximately $10.1 million as of December 31, 2022. The weighted-average period over which this compensation cost related to unvested employee awards will be recognized is 1.0 year and 0.6 years as of December 31, 2023 and December 31, 2022, respectively. There were no options granted during the years ended December 31, 2023, 2022 and 2021. The Company received approximately $20.9 million, $10.0 million and $14.9 million in cash proceeds from options exercised during the years ended December 31, 2023, 2022 and 2021, respectively. The intrinsic value of options exercised during the years ended December 31, 2023, 2022 and 2021 was approximately $565.9 million, $301.6 million and $579.6 million, respectively. The aggregate fair value of options vested during the years ended December 31, 2023, 2022 and 2021 was $12.5 million, $23.9 million and $28.1 million, respectively. Restricted Stock Units, Restricted Stock and Performance Stock Units The following table summarizes the activity for the Company’s unvested RSUs and PSUs: Shares Weighted-Average Aggregate Unvested and outstanding balance as of December 31, 2022 12,378,683 $ 106.19 $ 909,833 Awarded 7,382,006 89.09 Vested (4,794,318) 101.02 Forfeited/canceled (1,302,870) 102.42 Unvested and outstanding balance as of December 31, 2023 13,663,501 $ 99.13 $ 1,658,476 The Company issued a total of 122,224 shares of restricted Class A common stock in connection with acquisitions, net of shares retired, during the year ended December 31, 2023, which are subject to service-based vesting conditions over approximately four years from the respective grant dates. Total compensation cost related to unvested RSUs and restricted shares of common stock not yet recognized was approximately $1,187.3 million and $1,151.1 million as of December 31, 2023 and December 31, 2022, respectively. The weighted-average period over which this compensation cost related to unvested RSUs and restricted shares of common stock will be recognized is 2.8 years and 2.9 years as of December 31, 2023 and December 31, 2022, respectively. Total compensation cost related to unvested PSUs not yet recognized was approximately $25.1 million and $19.0 million as of December 31, 2023, and December 31, 2022, respectively. The weighted-average period over which this compensation cost related to unvested PSUs will be recognized is 1.3 years and 1.4 years as of December 31, 2023, and December 31, 2022, respectively. There were no PSUs outstanding during the year ended December 31, 2021. Stock-Based Compensation Stock-based compensation was included in the consolidated statement of operations as follows (in thousands): Year Ended December 31, 2023 2022 2021 Cost of revenue $ 17,578 $ 10,827 $ 4,565 Research and development 313,096 237,120 101,942 Sales and marketing 101,937 76,735 35,035 General and administrative 49,689 38,472 22,195 Stock-based compensation, net of amounts capitalized 482,300 363,154 163,737 Capitalized stock-based compensation 13,597 14,853 9,660 Total stock-based compensation $ 495,897 $ 378,007 $ 173,397 Employee Stock Purchase Plan In September 2019, the Board adopted and approved the 2019 ESPP, which became effective on the date of the final prospectus for the Company’s IPO. The ESPP is implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of the Company’s Class A common stock on specified dates during such offerings. Under the ESPP, the Company may specify offerings with durations of not more than 27 months and may specify shorter purchase periods within each offering. Historically offering periods have been approximately 6 months. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s Class A common stock on the first trading day of the offering period, or (2) the fair market value of the Company’s Class A common stock on the purchase date, as defined in the ESPP. The Company recognized $16.0 million, $11.2 million, and $7.6 million of stock-based compensation expense related to the ESPP during the years ended December 31, 2023, 2022, and 2021, respectively. As of December 31, 2023, and 2022, $6.6 million and $6.0 million, respectively has been withheld on behalf of employees for a future purchase under the ESPP due to the timing of payroll deductions. During the years ended December 31, 2023, 2022, and 2021 , the Company issued 517,430, 316,875, and 291,871 shares of Class A common stock under the ESPP. As of December 31, 2023, 17,481,059 shares of Class A common stock remain available for grant under the ESPP. Total compensation cost related to the ESPP not yet recognized was approximately $6.8 million and $7.1 million as of December 31, 2023 and 2022, respectively. The weighted average period over which this compensation cost will be recognized is 0.4 years as of December 31, 2023 and 2022, respectively.

Interest Income and Other Incom

Interest Income and Other Income, Net	12 Months Ended
	Dec. 31, 2023
Interest and Other Income [Abstract]
Interest Income and Other Income, Net	Interest Income and Other Income, Net Interest income and other income, net consist of the following (in thousands): Year Ended December 31, 2023 2022 2021 Interest income $ 103,459 $ 34,931 $ 21,412 Other (loss) income, net (3,458) 2,229 374 Interest income and other income, net $ 100,001 $ 37,160 $ 21,786

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income Taxes — For financial reporting purposes, income (loss) before income taxes, includes the following components (in thousands): Year Ended December 31, 2023 2022 2021 Domestic $ 42,811 $ (76,694) $ (29,617) Foreign 17,424 38,624 11,195 Income (loss) before income taxes $ 60,235 $ (38,070) $ (18,422) Total income taxes allocated to operations for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands): 2023 Current Deferred Total Federal $ (261) $ — $ (261) State 2,551 — 2,551 Foreign 10,262 (885) 9,377 Total $ 12,552 $ (885) $ 11,667 2022 Current Deferred Total Federal $ 3,122 $ — $ 3,122 State 183 — 183 Foreign 9,179 (394) 8,785 Total $ 12,484 $ (394) $ 12,090 2021 Current Deferred Total Federal $ 232 $ — $ 232 State 44 — 44 Foreign 2,091 (44) 2,047 Total $ 2,367 $ (44) $ 2,323 Tax Rate Reconciliation —Income tax expense was $11.7 million, $12.1 million and $2.3 million for the years ended December 31, 2023, 2022 and 2021, respectively, and differed from the amounts computed by applying the U.S. federal statutory income tax rate of 21% for the years ended December 31, 2023, 2022 and 2021, to pretax income (loss) from operations as a result of the following (in thousands): Year Ended December 31, 2023 2022 2021 Income tax expense at federal statutory rate $ 12,650 $ (7,995) $ (3,868) Meals and entertainment 1,957 1,717 416 State taxes (net of federal benefit) 1,090 140 18 Net change in valuation allowance 68,770 25,573 62,173 Uncertain tax positions (94) 3 (728) U.S. tax costs on international operations 2,037 5,722 1,478 Foreign taxes 1,149 (835) 424 Share based compensation deductions (69,784) (1,580) (57,350) Return to provision (3,335) (1,149) (193) U.S. R&D tax credits (2,973) (9,467) — Other 200 (39) (47) Total $ 11,667 $ 12,090 $ 2,323 Certain reclassifications have been made to the components of Tax Rate Reconciliation for the year ending December 31, 2022 and 2021 to conform to the 2023 presentation. For the year ended December 31, 2023, the Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized in the United States. Due to uncertainties surrounding the realization of the deferred tax assets, the Company recorded a full valuation allowance against substantially all of its net deferred tax assets. When the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets would have the effect of increasing net income in the period such determination is made. The Company is subject to tax laws in the United States and numerous foreign jurisdictions. The United States and many international legislative and regulatory bodies continually propose and enact legislation that could significantly impact how U.S. multinational corporations are taxed. The Company is closely monitoring proposed legislation and its potential impact. For tax years beginning on or after January 1, 2022, the Tax Cuts and Jobs Act of 2017 eliminates the option to deduct research and development expenditures, as defined under IRC Section 174, in the year incurred. Instead, taxpayers are required to amortize such expenditures over five years if incurred in the U.S. and over fifteen years if incurred in a foreign jurisdiction. Components of Deferred Taxes —The tax effects of temporary differences that give rise to the deferred tax assets and deferred tax liabilities at December 31, 2023 and 2022 are presented below (in thousands): December 31, 2023 2022 Deferred tax assets: Net operating losses $ 49,057 $ 54,974 U.S. R&D tax credits 46,639 13,841 Stock-based compensation 47,652 48,872 Section 174 capitalization 181,721 76,625 Lease liability 27,004 18,793 Other 21,593 15,494 Total deferred tax assets $ 373,666 $ 228,599 Less: valuation allowance (321,612) (188,817) Deferred tax assets, net of valuation allowance $ 52,054 $ 39,782 Deferred tax liabilities: Commissions (29,782) (22,182) Right of use asset (20,916) (17,151) Total deferred tax liabilities $ (50,698) $ (39,333) Deferred tax assets, net $ 1,356 $ 449 The Company accounts for income taxes using an asset and liability method and deferred income tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets and liabilities are expected to be realized or settled. The Company’s deferred tax assets and liabilities consist primarily of federal and state net operating loss carryforwards and basis differences for financial reporting and tax purposes of certain assets and liabilities. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based upon the weight of all available evidence, which includes the historical operating performance and the recorded cumulative losses in prior fiscal periods, management does not believe as of December 31, 2023 and 2022 that it is more likely than not that the Company will realize its U.S. deferred tax assets. As a result, a valuation allowance of $321.6 million and $188.8 million has been provided at December 31, 2023 and 2022, respectively. The valuation allowance changed by $132.8 million and $40.2 million at December 31, 2023 and 2022, respectively. Certain reclassifications have been made to the components of deferred tax for the year ending December 31, 2022 to conform to the 2023 presentation. At December 31, 2023 and 2022, the Company has net operating loss carryforwards for federal tax purposes of approximately $148.9 million and $243.4 million, respectively, which is available to offset federal taxable income. The federal net operating loss carryforwards generated at December 31, 2017 and prior will begin to expire in 2031, if not utilized. Net operating losses generated after December 31, 2017 have an indefinite carryforward period but are subject to an 80% of taxable income limitation after December 31, 2020. The Company has approximately $206.4 million and $92.0 million of post-apportioned net operating loss carryforwards as of December 31, 2023 and 2022, respectively for various state tax purposes. The state net operating loss carryforwards will begin to expire in 2026, if not utilized. Generally, the utilization of net operating losses may be subject to an annual limitation provided for in the Internal Revenue Code of 1986, as amended, under Section 382 and similar state codes. The Company has prepared an analysis to determine whether its net operating losses may be limited under such provisions. It has been determined that any annual limitation would not result in the expiration of net operating loss carryforwards before utilization. In general, it is the practice and intention of the Company to reinvest the earnings of its non-U.S. subsidiaries in those operations. Historically, the Company has not made a provision for U.S. income tax with respect to accumulated earnings of foreign subsidiaries where the foreign investment of such earnings is essentially permanent in duration. Generally, such amounts would become subject to U.S. taxation upon the remittance of dividends and under certain other circumstances. The Company has not provided U.S. taxes on unremitted earnings of its foreign subsidiaries as it asserts permanent reinvestment on any accumulated earnings and profits. Consistent with the provisions of ASC 740, Income Taxes , the Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The following table shows the changes in the gross amount of unrecognized tax benefits as of December 31, 2023 , 2022 and 2021 (in thousands): December 31, 2023 2022 2021 Beginning balance $ 106 $ 106 $ 532 Increases based on tax positions during the current period — — — (Decreases) based on tax positions during the current period (47) — (426) Ending balance $ 59 $ 106 $ 106 The total amount of unrecognized tax benefits that, if recognized would impact the effective tax rate would be $0.1 million for the year ended December 31, 2023. The Company’s policy for classifying interest and penalties associated with unrecognized income tax benefits is to include such items in income tax expense. The total amount of interest and penalties associated with unrecognized income tax benefits is $0.1 million and $0.1 million for the years ended December 31, 2023 and 2022. It is reasonably possible that certain unrecognized tax benefits may increase or decrease within the next 12 months due to tax examination changes, settlement activities, expirations of statute of limitations, or the impact on recognition and measurement considerations related to the results of published tax cases or other similar activities. As such the Company anticipates insignificant changes to unrecognized tax benefits over the next 12 months. The Company files income tax returns in the U.S. federal jurisdiction, various state jurisdictions and in various international jurisdictions. Tax years 2017 and forward generally remain open for examination for federal and state tax purposes. To the extent utilized in future years’ tax returns, net operating loss carryforwards at December 31, 2023 and 2022 will remain subject to examination until the respective tax year is closed.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic and diluted net income (loss) per common share is presented in conformity with the two-class method required for participating securities. Immediately prior to the consummation of the Company’s IPO in September 2019, all outstanding shares of convertible preferred stock and common stock were converted into shares of Class B common stock. As a result, Class A and Class B common stock are the only outstanding equity in the Company. Basic and diluted net income (loss) per share is computed using the weighted-average number of common shares of common stock outstanding during the period. The undistributed earnings are allocated based on the contractual participation rights of the Class A and Class B common stock as if the earnings for the year have been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis. Further, as the conversion of Class B common stock is assumed in the computation of the diluted net loss per share of Class A common stock, the undistributed earnings are equal to net loss for that computation. The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except per share data): Year Ended December 31, 2023 2022 2021 Basic net income (loss) per share: Class A Class B Class A Class B Class A Class B Numerator: Net income (loss) $ 44,684 $ 3,884 $ (45,163) $ (4,997) $ (16,177) $ (4,568) Denominator: Weighted average shares used in calculating net income (loss) per share, basic 298,116 25,918 283,989 31,421 240,999 68,049 Basic net income (loss) per share $ 0.15 $ 0.15 $ (0.16) $ (0.16) $ (0.07) $ (0.07) Diluted net income (loss) per share: Numerator: Allocation of distributed income (loss) for basic computation $ 44,684 $ 3,884 $ (45,163) $ (4,997) $ (16,177) $ (4,568) Reallocation of undistributed income (loss) as a result of conversion of Class B to Class A shares 3,884 — (4,997) — (4,568) — Allocation of undistributed income (loss) $ 48,568 $ 3,884 $ (50,160) $ (4,997) $ (20,745) $ (4,568) Denominator: Number of shares used in basic calculation 298,116 25,918 283,989 31,421 240,999 68,049 Weighted average effect of diluted securities: Conversion of Class B to Class A common shares outstanding 25,918 — 31,421 — 68,049 — Employee stock options 14,828 — — — — — Employee stock purchase plan 15 — — — — — Restricted stock units and performance stock units 2,731 — — — — — Unvested restricted stock in connection with acquisitions 586 — — — — — Shares issuable upon conversion of the convertible senior notes 8,098 — — — — — Number of shares used in diluted calculation 350,292 25,918 315,410 31,421 309,048 68,049 Diluted net income (loss) per share $ 0.14 $ 0.15 $ (0.16) $ (0.16) $ (0.07) $ (0.07) For the periods presented where the Company was in a loss position, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): Year Ended December 31, 2023 2022 2021 Shares subject to outstanding stock options and RSUs 2,248 30,931 29,454 Unvested early exercised stock options and restricted shares of common stock 31 1,120 946 Shares subject to the employee stock purchase plan — 316 94 Shares issuable upon conversion of the convertible senior notes — 8,098 8,098 Total 2,279 40,465 38,592 ASU No. 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share when the instruments may be settled in cash or shares. See Note 2, Basis of Presentation and Summary of Significant Accounting Policies—Accounting Policies Recently Adopted for more information. During the three months ended December 31, 2023, the conditional conversion feature of the 2025 Notes was not triggered and the 2025 Notes are not convertible, in whole or in part, at the option of the holders between January 1, 2024 through March 31, 2024. The Company uses the if-converted method for calculating any potential dilutive effect of the conversion options embedded in the 2025 Notes on diluted net income per share; however, since the Company is in a net loss position, there was no dilutive effect during any period presented. The Company entered into Capped Calls in connection with the issuance of the 2025 Notes. The effect of the Capped Calls was also excluded from the calculation of diluted net income per share as the effect of the Capped Calls would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to the Company’s Class A common stock upon any conversion of the 2025 Notes.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net income (loss)	$ 48,568	$ (50,160)	$ (20,745)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Dec. 31, 2023 shares	Dec. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the three months ended December 31, 2023 , the Company’s directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted written plans intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) for the sale of the Company’s securities as set forth in the table below. Name Position Adoption Date Total Shares of Class A Common Stock to be Sold Expiration Date David Obstler Chief Financial Officer December 10, 2023 200,000 (1) March 15, 2025 Armelle de Madre Chief People Officer December 12, 2023 Up to 72,870 (2) March 31, 2025 Dev Ittycheria Director December 12, 2023 135,000 February 28, 2025 Sean Walters Chief Revenue Officer December 14, 2023 Up to 86,510 (2) February 11, 2025 (1) The amount includes 100,000 shares to be sold under the Rule 10b5-1 trading plan by the Obstler Children 2019 Trust. (2) The actual number of shares that will be sold under the Rule 10b5-1 trading plan will be reduced by the number of shares sold pursuant to the Company’s election under its equity incentive plans to require the satisfaction of tax withholding obligations realized upon the vesting of RSUs and PSUs to be funded by a sell-to-cover transaction. The number of Company shares to be sold to satisfy the Company’s tax withholding obligation is not known at this time as it is dependent on future events, including the future trading price of the Company’s shares.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
David Obstler [Member]
Trading Arrangements, by Individual
Name	David Obstler
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 10, 2023
Arrangement Duration	461 days
Aggregate Available	200,000	200,000
Armelle de Madre [Member]
Trading Arrangements, by Individual
Name	Armelle de Madre
Title	Chief People Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 12, 2023
Arrangement Duration	475 days
Aggregate Available	72,870	72,870
Dev Ittycheria [Member]
Trading Arrangements, by Individual
Name	Dev Ittycheria
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 12, 2023
Arrangement Duration	444 days
Aggregate Available	135,000	135,000
Sean Walters [Member]
Trading Arrangements, by Individual
Name	Sean Walters
Title	Chief Revenue Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 14, 2023
Arrangement Duration	425 days
Aggregate Available	86,510	86,510
Obstler Children 2019 Trust Shares [Member] | David Obstler [Member]
Trading Arrangements, by Individual
Aggregate Available	100,000	100,000

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Datadog, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Segment Information	Segment Information The Company has a single operating and reportable segment as well as one business activity, monitoring and providing analytics on companies’ information technology (“IT”) infrastructure. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. There are no segment managers who are held accountable for operations or results below the consolidated level.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates include the fair value of marketable securities, the allowance for credit losses , the fair value of acquired assets and assumed liabilities from business combinations, useful lives of property, equipment, software, and finite lived intangibles, stock-based compensation, valuation of long-lived assets and their recoverability, including goodwill, the incremental borrowing rate for operating leases, estimated expected period of benefit for deferred contract costs, fair value of the liability component of the convertible debt, realization of deferred tax assets and uncertain tax positions, revenue recognition and the allocation of overhead costs between cost of revenue and operating expenses. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could materially differ from these estimates.
Foreign Currency Translation	Foreign Currency Translation The reporting currency of the Company is the United States dollar (“USD”). The functional currency of the Company is USD, and the functional currency of the Company’s subsidiaries is generally the local currency of the jurisdiction in which the foreign subsidiary is located. The assets and liabilities of the Company’s subsidiaries are translated to USD at exchange rates in effect at the balance sheet date. All income statement accounts are translated at monthly average exchange rates. Resulting foreign currency translation adjustments are recorded directly in accumulated other comprehensive loss as a separate component of stockholders’ equity. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income, net in the accompanying consolidated statements of operations when realized and have not been material for any of the periods presented.
Revenue Recognition	Revenue Recognition The Company generates revenue from the sale of subscriptions to customers using its cloud-based platform. The terms of the Company’s subscription agreements are primarily monthly, annual or multi-year. The Company’s customers can enter into (1) a subscription agreement for a committed contractual amount of usage that is apportioned ratably on a monthly basis over the term of the subscription period, (2) a subscription agreement for a committed contractual amount of usage that is delivered as used, or (3) a monthly subscription based on usage. The Company typically bills customers on an annual or multi-year subscription in advance, with any usage in excess of the committed contracted amount billed monthly in arrears. The Company typically bills customers on a monthly plan in arrears. Customers also have the option to purchase additional services priced at rates at or above the stand-alone selling price. The Company accounts for revenue contracts with customers through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation. The Company’s revenue arrangements may include infrastructure monitoring, application performance monitoring, log management, synthetics monitoring, security monitoring, continuous profiling, serverless monitoring, network monitoring, real user monitoring and incident management as well as secondary services including custom metrics in dashboard monitoring, docker container monitoring, and indexed spans. The Company has identified each service as a separate performance obligation. The transaction price is based on the fixed price for the contracted level of service plus variable consideration for additional optional purchases. Billing periods correspond to the periods over which services are performed and there are no discounts given on the purchase of future services. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on a range of actual prices charged to customers. Revenue is recognized when control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. The Company determined an output method, recognition over time, to be the most appropriate measure of progress because it most faithfully represents when the value of the services is simultaneously received and consumed by the customer, and control is transferred. For committed contractual amounts of usage, revenue is recognized ratably over the term of the subscription agreement generally beginning on the date that the platform is made available to a customer. For committed contractual amount of usage that is delivered as used, a monthly subscription based on usage, or usage in excess of a ratable subscription, the Company recognizes revenue as the product is used. Subscription revenue excludes sales and other indirect taxes. The Company applied the practical expedient in Topic 606 and did not evaluate contracts of one year or less for the existence of a significant financing component. Deferred Revenue and Remaining Performance Obligations Certain of the Company’s customers pay in advance of satisfaction of performance obligations and other customers with monthly contract terms are billed in arrears on a monthly basis. The Company records contract liabilities to deferred revenue when customers are billed or when the Company receives customer payments in advance of the performance obligations being satisfied on the Company’s contracts. Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligations include deferred revenue, multi-year contracts with future installment payments and certain unfulfilled orders against accepted customer contracts at the end of any given period.
Convertible Senior Notes	Convertible Senior Notes In accounting for the issuance of the Company’s convertible senior notes (the “2025 Notes”), the 2025 Notes were separated into liability and equity components through December 31, 2020. The carrying amounts of the liability component was calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the respective 2025 Notes. This difference represents the debt discount that is amortized to interest expense over the contractual terms of the 2025 Notes using the effective interest rate method. The equity component was recorded in additional paid-in capital. In accounting for the debt issuance costs related to the 2025 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2025 Notes in the same proportion as the allocation of the proceeds. Issuance costs attributable to the liability component are being amortized to interest expense over the contractual terms of the 2025 Notes. The issuance costs attributable to the equity component were netted against the equity component in additional paid-in capital.
Cost of Revenue	Cost of Revenue Cost of revenue consists primarily of costs related to providing subscription services to paying customers, including data center and networking expenses, employee compensation (including stock-based compensation) and other employee-related expenses for customer experience and technical operations staff, payments to outside service providers, payment processing fees, amortization of capitalized internally developed software costs and acquired developed technology, and allocated overhead costs.
Research and Development Costs	Research and Development Costs Research and development costs are expensed as incurred. Research and development costs consist of employee compensation (including stock-based compensation) and other employee-related expenses, materials and supplies, and allocated overhead costs such as rent and facilities costs.
Sales and Marketing Costs	Sales and Marketing Costs Sales and marketing costs consist primarily of personnel costs for the Company’s sales and marketing organization, including stock-based compensation and commissions, costs of general marketing and promotional activities, including the free tier and introductory trials of the Company’s products, travel-related expenses, amortization of acquired customer relationships, and allocated overhead costs.
Advertising Costs	Advertising Costs Advertising costs are expensed as incurred and were approximately $21.8 million, $25.5 million and $20.8 million for the years ended December 31, 2023, 2022 and 2021, respectively, and are included in sales and marketing expense in the accompanying consolidated statement of operations.
Income Taxes	Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts for financial reporting and the tax bases of assets and liabilities. The deferred assets and liabilities are recorded at the statutorily enacted tax rates anticipated to be in effect when such temporary differences reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance is established; when based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company engages in transactions in which the tax consequences may be subject to uncertainty. The Company accounts for uncertain tax positions based on an evaluation as to whether it is more likely than not that a tax position will be sustained on audit, including resolution of any related appeals or litigation processes. This evaluation is based on all available evidence and assumes that the appropriate tax authorities have full knowledge of all relevant information concerning the tax position. The Company accounts for uncertain tax positions as non-current tax liabilities or through a reduction of a corresponding deferred tax asset. The tax benefit recognized is based on the largest amount that is greater than 50% likely of being realized upon ultimate settlement. The Company includes potential interest expense and penalties related to its uncertain tax positions in income tax expense.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes and measures compensation expense for all stock-based payment awards granted to employees, directors, and nonemployees, including stock options, restricted stock units (“RSUs”), performance-based awards (“PSUs”), and the employee stock purchase plan (the “ESPP”) based on the fair value of the awards on the date of grant. The fair value of each stock option granted is estimated using the Black-Scholes option pricing model. The determination of the grant date fair value using an option-pricing model is affected by the estimated fair value of the Company’s Class A common stock as well as assumptions regarding a number of other complex and subjective variables. These variables include expected stock price volatility over the expected term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate for the expected term of the award and expected dividends. The fair value of RSUs and PSUs is determined by the closing price on the date of grant of the Company’s Class A common stock, as reported on The Nasdaq Global Select Market. The Company estimates the fair value of the rights to acquire stock under the ESPP using the Black-Scholes option pricing model. Stock-based compensation for stock options and RSUs is recognized on a straight-line basis over the requisite service period and account for forfeitures as they occur. Stock-based compensation for PSUs is amortized under the accelerated attribution method and may be adjusted over the vesting period based on interim estimates of performance against pre-set objectives. PSUs will vest upon achievement of specified performance targets and subject to continuous service through the applicable vesting dates. The compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied and the Company accounts for forfeitures as they occur. The Company also has certain options that have performance-based vesting conditions; stock-based compensation expense for such awards is recognized on a straight-line basis from the time the vesting condition is likely to be met through the time the vesting condition has been achieved.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents consist of money market funds, corporate debt securities, and U.S. government treasury securities.
Marketable Securities	Marketable Securities The Company’s marketable securities consist of corporate debt securities, commercial paper, certificates of deposit, U.S. government treasury securities, and U.S. government agency securities. The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable securities as available-for-sale securities as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its marketable securities within current assets on the consolidated balance sheet. Available-for-sale securities are recorded at fair value each reporting period. Premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield using the effective interest method. Interest income is recognized when earned. Unrealized gains and losses on these marketable securities are presented net of tax and reported as a separate component of accumulated other comprehensive loss until realized. Realized gains and losses are determined based on the specific identification method and are reported in Interest income and other income, net in the consolidated statements of operations. The Company periodically evaluates its marketable securities to assess whether an investment’s fair value is less than its amortized cost basis and if the decline in the fair value is attributable to a credit loss. Declines in fair value judged to be related to credit loss are reported in Interest income and other income, net in the consolidated statements of operations.
Restricted Cash	Restricted Cash Restricted cash primarily consists of collateralized letters of credit established in connection with lease agreements for the Company’s facilities. Restricted cash is included in current assets for leases that expire within one year and is included in non-current assets for leases that expire in more than one year from the balance sheet date.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk primarily consist of cash and cash equivalents, marketable securities and accounts receivable. Cash deposits may, at times, exceed amounts insured by the Federal Deposit Insurance Corporation (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”). The Company has not experienced any losses on its deposits of cash and cash equivalents to date. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying consolidated balance sheets.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. The Company’s financial instruments consist of cash equivalents, marketable securities, accounts receivable, accounts payable and accrued expenses. Cash equivalents are stated at amortized cost, which approximates fair value at the balance sheet dates, due to the short period of time to maturity. Marketable securities are recorded at fair value. Accounts receivable, accounts payable, and accrued expenses are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable includes billed and unbilled receivables. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. The Company regularly reviews the adequacy of the allowance for credit losses by considering the age of each outstanding invoice and the collection history to determine the appropriate amount of allowance for credit losses. Accounts receivable deemed uncollectible are charged against the allowance for credit losses when identified. Unbilled accounts receivable represents revenue recognized on contracts for which billings have not yet been presented to customers because the amounts were earned but not contractually billable as of the balance sheet date, substantially all of which is expected to be billed and collected within one year.
Internal Use Software Development Costs	Internal-Use Software Development Costs The Company capitalizes qualifying internal-use software development costs related to its cloud platform. The costs consist of personnel costs (including related benefits and stock-based compensation) that are incurred during the application development stage. Capitalization of costs begins when two criteria are met: (1) the preliminary project stage is completed, and (2) it is probable that the software will be completed and used for its intended function. Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post implementation operating activities are expensed as incurred. Capitalized costs are included in property and equipment. These costs are amortized over the estimated useful life of the software, which is two years, on a straight-line basis, which represents the manner in which the expected benefit will be derived. The amortization of costs related to the platform applications is included in cost of revenue and sales and marketing expense based on an allocation between paid customer accounts and free customer accounts not generating revenue.
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net is stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful life of the related asset. Expenses that improve an asset or extend its remaining useful life are capitalized. Costs of maintenance or repairs that do not extend the lives of the respective assets are charged to expenses as incurred.
Deferred Contract Costs	Deferred Contract Costs Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. There are no sales commissions earned on renewals . These costs are deferred and then amortized over a period of benefit which is determined to be 4 years. The Company determined the period of benefit by taking into consideration the length of terms in its customer contracts, life of the technology and other factors . Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current; the remaining portion is recorded as deferred contract costs, non-current, in the consolidated balance sheets. Deferred contract costs are periodically analyzed for impairment. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of operations.
Business Combinations	Business Combinations When the Company acquires a business, the purchase consideration is allocated to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated respective fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require the Company to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired users, acquired technology, and trade names from a market participant perspective, useful lives and discount rates. The Company’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to other income, net in the consolidated statement of operations.
Accounting for Impairment of Long-Lived Assets (Including Goodwill and Intangibles)	Accounting for Impairment of Long-Lived Assets (Including Goodwill and Intangibles) Long-lived assets with finite lives include property and equipment, capitalized development software costs and acquired intangible assets. Long-lived assets are amortized over their estimated useful lives which are as follows: Computers and equipment 3 years Furniture and fixtures 5 years Leasehold improvements Shorter of lease term or useful life of asset Capitalized software development costs 2 years Developed technology 3 years Customer relationships 4 years The Company evaluates long lived assets, including acquired intangible assets and capitalized software development costs, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or the estimated useful life becomes shorter than originally estimated. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset exceeds these estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group, based on discounted cash flows. Goodwill is not amortized but rather tested for impairment at least annually on October 1, or more frequently if events or changes in circumstances indicate that goodwill may be impaired. Goodwill impairment is recognized when the quantitative assessment results in the carrying value exceeding the fair value, in which case an impairment charge is recorded to the extent the carrying value exceeds the fair value. The Company did not recognize any impairment of goodwill during the years ended December 31, 2023, 2022 or 2021.
Operating Leases	Operating Leases The Company determines if an arrangement is a lease at inception. Operating lease assets and liabilities are reflected within operating lease assets, operating lease liabilities, current, and operating lease liabilities, non-current, on the consolidated balance sheets. For short-term leases (an initial term of 12 months or less), an operating lease asset and corresponding lease liability are not recorded and the Company records rent expense in its consolidated statements of operations on a straight-line basis over the lease term. Operating lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company generally uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease assets also include any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for separately.
Net Income (Loss) Per Share Attributable to Common Shareholders	Net Income (Loss) Per Share Attributable to Common Stockholders Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of Class A common stock and Class B common stock (together “common stock ” ) outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period giving effect to all potentially dilutive securities to the extent they are dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net income (loss) per share by application of the two-class method. During the periods when the Company is in a net loss position, the net loss attributable to common stockholders was not allocated to the unvested common stock under the two-class method as these securities do not have a contractual obligation to share in the Company’s losses.
Accounting Pronouncements Recently Adopted / Not yet Adopted	Accounting Pronouncements Recently Adopted In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers ( “ ASU No. 2021-08”), which intends to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. It is effective for interim and annual periods beginning after December 15, 2022, with early adoption permitted. The Company early adopted ASU No. 2021-08 on January 1, 2022 on a prospective basis with no material impact on the Company's consolidated financial statements. Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07 , Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU No. 2023-07 ” ), which intends to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09 , Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU No. 2023-09 ” ), which intends to increase the transparency of income tax disclosures, particularly the rate reconciliation table and disclosures about income taxes paid. For public business entities, it is effective for annual periods beginning after December 15, 2024, and interim periods beginning after December 15, 2025, with early adoption permitted. The Company has not early adopted ASU No. 2023-09 as of December 31, 2023 and is evaluating its impact.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Long-lived Assets Estimated Useful Lives	Long-lived assets with finite lives include property and equipment, capitalized development software costs and acquired intangible assets. Long-lived assets are amortized over their estimated useful lives which are as follows: Computers and equipment 3 years Furniture and fixtures 5 years Leasehold improvements Shorter of lease term or useful life of asset Capitalized software development costs 2 years Developed technology 3 years Customer relationships 4 years

Marketable Securities (Tables)

Marketable Securities (Tables)	12 Months Ended
	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-Sale Marketable Securities	The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents on the consolidated balance sheet as of December 31, 2023 and December 31, 2022 (in thousands): December 31, 2023 Amortized Unrealized Unrealized Fair Corporate debt securities $ 776,323 $ 770 $ (1,140) $ 775,953 Commercial paper 605,291 570 (75) 605,786 U.S. government treasury securities 460,854 390 (1,399) 459,845 Certificates of deposit 264,405 335 (15) 264,725 U.S. government agency securities 146,611 — (361) 146,250 Marketable securities $ 2,253,484 $ 2,065 $ (2,990) $ 2,252,559 December 31, 2022 Amortized Unrealized Unrealized Fair Corporate debt securities $ 813,598 $ 64 $ (7,554) $ 806,108 Commercial paper 357,030 64 (821) 356,273 Certificates of deposit 174,080 37 (587) 173,530 U.S. government treasury securities 120,977 — (1,099) 119,878 U.S. government agency securities 89,718 12 (178) 89,552 Marketable securities $ 1,555,403 $ 177 $ (10,239) $ 1,545,341
Schedule of Fair Values of Available-for-Sale Marketable Securities, by Remaining Contractual Maturity	As of December 31, 2023, the fair values of available-for-sale marketable securities, by remaining contractual maturity, were as follows (in thousands): Due within one year $ 1,799,542 Due in one year through five years 453,017 Total $ 2,252,559

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value on a recurring basis as of December 31, 2023 and 2022, and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value (in thousands): Fair Value Measurement as of December 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 240,909 $ — $ — $ 240,909 Corporate debt securities — 484 — 484 U.S. government treasury securities — 53,972 — 53,972 Marketable Securities: Corporate debt securities — 775,953 — 775,953 Commercial paper — 605,786 — 605,786 Certificates of deposit — 264,725 — 264,725 U.S. government treasury securities — 459,845 — 459,845 U.S. government agency securities — 146,250 — 146,250 Total financial assets $ 240,909 $ 2,307,015 $ — $ 2,547,924 Fair Value Measurement as of December 31, 2022 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents: Money market funds $ 302,902 $ — $ — $ 302,902 Corporate debt securities — 2,493 — 2,493 Marketable Securities: Corporate debt securities — 806,108 — 806,108 Commercial paper — 356,273 — 356,273 Certificates of deposit — 173,530 — 173,530 U.S. government treasury securities — 119,878 — 119,878 U.S. government agency securities — 89,552 — 89,552 Total financial assets $ 302,902 $ 1,547,834 $ — $ 1,850,736

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Components of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): December 31, December 31, Computers and equipment $ 35,736 $ 33,376 Furniture and fixtures 17,202 13,315 Leasehold improvements 55,111 27,683 Capitalized software development costs 192,691 134,890 Total property and equipment $ 300,740 $ 209,264 Less: accumulated depreciation and amortization (128,868) (83,918) Total property and equipment, net $ 171,872 $ 125,346

Acquisitions, Intangible Asse_2

Acquisitions, Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2023
Acquisitions, Intangible Assets And Goodwill [Abstract]
Schedule of Intangible assets, Net	Intangible assets, net consisted of the following (in thousands): December 31, 2023 Gross Accumulated Net Amortization Developed technology $ 24,995 $ (16,428) $ 8,567 3 years Customer relationships 3,300 (2,250) 1,050 4 years Total $ 28,295 $ (18,678) $ 9,617 December 31, 2022 Gross Accumulated Net Amortization Developed technology $ 24,460 $ (9,970) $ 14,490 3 years Customer relationships 3,300 (1,425) 1,875 4 years Total $ 27,760 $ (11,395) $ 16,365
Schedule of Future Amortization Expense	As of December 31, 2023, future amortization expense by year is expected to be as follows (in thousands): Amount 2024 $ 6,489 2025 2,597 2026 531 Total $ 9,617
Schedule of Changes in Carrying Amount of Goodwill	The changes in the carrying amount of goodwill were as follows (in thousands): Amount Balance as of December 31, 2022 $ 348,277 2023 Acquisitions 3,540 Foreign currency translation adjustments 877 Balance as of December 31, 2023 $ 352,694

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): December 31, December 31, Accrued cloud hosting and infrastructure expenses (1) $ 13,783 $ 73,566 Accrued compensation and commissions 61,541 46,736 Other tax liability and sales tax 30,775 25,818 Other accrued expenses 21,532 25,038 Total accrued expenses and other current liabilities $ 127,631 $ 171,158 _____________________ 1) Due to the timing of when invoices are received, accounts payable on the consolidated balance sheets includes cloud hosting and infrastructure expenses of $70.2 million and $12.6 million for the years ended December 31, 2023 and 2022, respectively.

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Schedule of Net Carrying Amount of Liability and Equity Component of 2025 Notes	The net carrying amount of the liability component of the 2025 Notes was as follows (in thousands): December 31, December 31, Convertible senior notes, net: Principal $ 747,496 $ 747,496 Unamortized debt issuance costs (5,261) (8,649) Net carrying amount $ 742,235 $ 738,847
Schedule of Interest Expense Related to 2025 Notes	The following table sets forth the interest expense related to the 2025 Notes for the years ended December 31, 2023, 2022, and 2021 (in thousands): Year Ended December 31, 2023 2022 2021 Contractual interest expense $ 934 $ 934 $ 934 Amortization of issuance costs 3,388 3,369 3,349 Total $ 4,322 $ 4,303 $ 4,283

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Schedule of Components of Lease Cost Recognized	The components of lease cost recognized within the Company’s consolidated statements of operations were as follows (in thousands): Year Ended December 31, 2023 2022 2021 Operating lease cost (1) $ 34,670 $ 25,212 $ 20,198 Short-term lease cost 8,797 8,739 3,609 _____________________ 1) Includes non-cash lease expense of $26.4 million, $21.4 million, and $17.2 million for the years ended December 31, 2023, 2022 and 2021, respectively.
Schedule of Supplemental Cash Flow Information and Non-cash Activity	Supplemental cash flow information and non-cash activity related to the Company’s operating leases are as follows (in thousands): Year Ended December 31, 2023 2022 2021 Cash paid for amounts included in measurement of lease liabilities $ 13,273 $ 24,752 $ 20,741 Operating lease assets obtained in exchange for new lease liabilities 61,594 48,404 17,476
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities by fiscal year for the Company’s operating leases are as follows (in thousands): Amount 2024 $ 17,995 2025 34,234 2026 31,050 2027 27,747 2028 24,479 Thereafter 73,102 Total lease payments $ 208,607 Less: imputed interest (48,505) Present value of lease liabilities $ 160,102
Schedule of Weighted Average Remaining Lease Term and Discount Rate	Weighted average remaining lease term and discount rate for the Company’s operating leases are as follows: December 31, December 31, Weighted average remaining lease term (years) 6.7 6.2 Weighted average discount rate 6.00% 5.12%

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Geographic Area	Revenue by location is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Year Ended December 31, 2023 2022 2021 North America (1) $ 1,487,319 $ 1,200,719 $ 736,218 International 641,040 474,381 292,566 Total $ 2,128,359 $ 1,675,100 $ 1,028,784 1) Includes revenue from the United States of $1,411.0 million, $1,134.1 million, and $691.8 million for the years ended December 31, 2023, 2022, and 2021, respectively.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Summary of Reserved Shares of Common Stock for Future Issuance	As of December 31, 2023 and 2022, the Company had reserved shares of common stock for future issuance as follows: December 31, 2023 2022 Options, RSUs and PSUs outstanding 25,741,136 30,930,540 Shares available for future grants 73,189,660 63,291,013 Shares subject to the employee stock purchase plan 17,481,059 14,806,591 Total shares of common stock reserved for future issuance 116,411,855 109,028,144
Summary of Stock Option Activity and Weighted Average Exercise Prices	The following table summarizes the Company's stock option activity and weighted-average exercise prices: Number of Weighted- Weighted- Aggregate Balance—December 31, 2022 18,551,857 $ 3.24 4.4 $ 1,303,464 Options granted — — Options exercised (6,455,931) 3.24 Options forfeited or expired (18,291) 5.50 Balance—December 31, 2023 12,077,635 $ 3.24 3.4 $ 1,426,912 Exercisable—December 31, 2023 12,074,409 $ 3.23 3.4 $ 1,426,607
Summary of Activity for Unvested RSUs	The following table summarizes the activity for the Company’s unvested RSUs and PSUs: Shares Weighted-Average Aggregate Unvested and outstanding balance as of December 31, 2022 12,378,683 $ 106.19 $ 909,833 Awarded 7,382,006 89.09 Vested (4,794,318) 101.02 Forfeited/canceled (1,302,870) 102.42 Unvested and outstanding balance as of December 31, 2023 13,663,501 $ 99.13 $ 1,658,476
Share-Based Payment Arrangement, Performance Shares, Activity	The following table summarizes the activity for the Company’s unvested RSUs and PSUs: Shares Weighted-Average Aggregate Unvested and outstanding balance as of December 31, 2022 12,378,683 $ 106.19 $ 909,833 Awarded 7,382,006 89.09 Vested (4,794,318) 101.02 Forfeited/canceled (1,302,870) 102.42 Unvested and outstanding balance as of December 31, 2023 13,663,501 $ 99.13 $ 1,658,476
Summary of Stock-based Compensation Expense	Stock-based compensation was included in the consolidated statement of operations as follows (in thousands): Year Ended December 31, 2023 2022 2021 Cost of revenue $ 17,578 $ 10,827 $ 4,565 Research and development 313,096 237,120 101,942 Sales and marketing 101,937 76,735 35,035 General and administrative 49,689 38,472 22,195 Stock-based compensation, net of amounts capitalized 482,300 363,154 163,737 Capitalized stock-based compensation 13,597 14,853 9,660 Total stock-based compensation $ 495,897 $ 378,007 $ 173,397

Interest Income and Other Inc_2

Interest Income and Other Income, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Interest and Other Income [Abstract]
Schedule of Interest Income and Other Income, Net	Interest income and other income, net consist of the following (in thousands): Year Ended December 31, 2023 2022 2021 Interest income $ 103,459 $ 34,931 $ 21,412 Other (loss) income, net (3,458) 2,229 374 Interest income and other income, net $ 100,001 $ 37,160 $ 21,786

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Components of Loss Before Income Taxes	Income Taxes — For financial reporting purposes, income (loss) before income taxes, includes the following components (in thousands): Year Ended December 31, 2023 2022 2021 Domestic $ 42,811 $ (76,694) $ (29,617) Foreign 17,424 38,624 11,195 Income (loss) before income taxes $ 60,235 $ (38,070) $ (18,422)
Schedule of Income Taxes Allocated to Operations	Total income taxes allocated to operations for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands): 2023 Current Deferred Total Federal $ (261) $ — $ (261) State 2,551 — 2,551 Foreign 10,262 (885) 9,377 Total $ 12,552 $ (885) $ 11,667 2022 Current Deferred Total Federal $ 3,122 $ — $ 3,122 State 183 — 183 Foreign 9,179 (394) 8,785 Total $ 12,484 $ (394) $ 12,090 2021 Current Deferred Total Federal $ 232 $ — $ 232 State 44 — 44 Foreign 2,091 (44) 2,047 Total $ 2,367 $ (44) $ 2,323
Schedule of Tax Rate Reconciliation	Tax Rate Reconciliation —Income tax expense was $11.7 million, $12.1 million and $2.3 million for the years ended December 31, 2023, 2022 and 2021, respectively, and differed from the amounts computed by applying the U.S. federal statutory income tax rate of 21% for the years ended December 31, 2023, 2022 and 2021, to pretax income (loss) from operations as a result of the following (in thousands): Year Ended December 31, 2023 2022 2021 Income tax expense at federal statutory rate $ 12,650 $ (7,995) $ (3,868) Meals and entertainment 1,957 1,717 416 State taxes (net of federal benefit) 1,090 140 18 Net change in valuation allowance 68,770 25,573 62,173 Uncertain tax positions (94) 3 (728) U.S. tax costs on international operations 2,037 5,722 1,478 Foreign taxes 1,149 (835) 424 Share based compensation deductions (69,784) (1,580) (57,350) Return to provision (3,335) (1,149) (193) U.S. R&D tax credits (2,973) (9,467) — Other 200 (39) (47) Total $ 11,667 $ 12,090 $ 2,323
Schedule of Components of Deferred Tax Assets and Liabilities	Components of Deferred Taxes —The tax effects of temporary differences that give rise to the deferred tax assets and deferred tax liabilities at December 31, 2023 and 2022 are presented below (in thousands): December 31, 2023 2022 Deferred tax assets: Net operating losses $ 49,057 $ 54,974 U.S. R&D tax credits 46,639 13,841 Stock-based compensation 47,652 48,872 Section 174 capitalization 181,721 76,625 Lease liability 27,004 18,793 Other 21,593 15,494 Total deferred tax assets $ 373,666 $ 228,599 Less: valuation allowance (321,612) (188,817) Deferred tax assets, net of valuation allowance $ 52,054 $ 39,782 Deferred tax liabilities: Commissions (29,782) (22,182) Right of use asset (20,916) (17,151) Total deferred tax liabilities $ (50,698) $ (39,333) Deferred tax assets, net $ 1,356 $ 449
Schedule of Changes in Gross Amount of Unrecognized Tax Benefits	The following table shows the changes in the gross amount of unrecognized tax benefits as of December 31, 2023 , 2022 and 2021 (in thousands): December 31, 2023 2022 2021 Beginning balance $ 106 $ 106 $ 532 Increases based on tax positions during the current period — — — (Decreases) based on tax positions during the current period (47) — (426) Ending balance $ 59 $ 106 $ 106

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Share	The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except per share data): Year Ended December 31, 2023 2022 2021 Basic net income (loss) per share: Class A Class B Class A Class B Class A Class B Numerator: Net income (loss) $ 44,684 $ 3,884 $ (45,163) $ (4,997) $ (16,177) $ (4,568) Denominator: Weighted average shares used in calculating net income (loss) per share, basic 298,116 25,918 283,989 31,421 240,999 68,049 Basic net income (loss) per share $ 0.15 $ 0.15 $ (0.16) $ (0.16) $ (0.07) $ (0.07) Diluted net income (loss) per share: Numerator: Allocation of distributed income (loss) for basic computation $ 44,684 $ 3,884 $ (45,163) $ (4,997) $ (16,177) $ (4,568) Reallocation of undistributed income (loss) as a result of conversion of Class B to Class A shares 3,884 — (4,997) — (4,568) — Allocation of undistributed income (loss) $ 48,568 $ 3,884 $ (50,160) $ (4,997) $ (20,745) $ (4,568) Denominator: Number of shares used in basic calculation 298,116 25,918 283,989 31,421 240,999 68,049 Weighted average effect of diluted securities: Conversion of Class B to Class A common shares outstanding 25,918 — 31,421 — 68,049 — Employee stock options 14,828 — — — — — Employee stock purchase plan 15 — — — — — Restricted stock units and performance stock units 2,731 — — — — — Unvested restricted stock in connection with acquisitions 586 — — — — — Shares issuable upon conversion of the convertible senior notes 8,098 — — — — — Number of shares used in diluted calculation 350,292 25,918 315,410 31,421 309,048 68,049 Diluted net income (loss) per share $ 0.14 $ 0.15 $ (0.16) $ (0.16) $ (0.07) $ (0.07)
Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations	For the periods presented where the Company was in a loss position, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): Year Ended December 31, 2023 2022 2021 Shares subject to outstanding stock options and RSUs 2,248 30,931 29,454 Unvested early exercised stock options and restricted shares of common stock 31 1,120 946 Shares subject to the employee stock purchase plan — 316 94 Shares issuable upon conversion of the convertible senior notes — 8,098 8,098 Total 2,279 40,465 38,592

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Dec. 31, 2023 USD ($) segment	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 02, 2020 USD ($)
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Number of operating segment | segment	1
Number of reportable segment | segment	1
Stockholders' equity	$ 2,025,354,000	$ 1,410,505,000	$ 1,041,203,000		$ 957,432,000
Convertible senior notes, net	$ 742,235,000	738,847,000
Deferred contract costs amortization period	4 years
Impairment of goodwill	$ 0	$ 0	0
Capitalized software development costs
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Property and equipment, useful lives	2 years
United States | Long-Lived Assets | Geographic Concentration Risk
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	67%	66%
Outside of United States | Long-Lived Assets | Geographic Concentration Risk
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	33%	34%
Sales and marketing
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Advertising costs	$ 21,800,000	$ 25,500,000	20,800,000
Accumulated Deficit
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity	(153,698,000)	(202,266,000)	(152,106,000)		(148,163,000)
Additional Paid-in Capital
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity	2,181,267,000	1,625,190,000	$ 1,197,136,000		1,103,305,000
Cumulative Effect, Period of Adoption, Adjustment
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity					(156,268,000)
Cumulative Effect, Period of Adoption, Adjustment | ASU No. 2020-06
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Convertible senior notes, net				$ 156,300,000
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity					16,802,000
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit | ASU No. 2020-06
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity				16,800,000
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity					$ (173,070,000)
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital | ASU No. 2020-06
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Stockholders' equity				$ (173,100,000)
0.125% Convertible Senior Notes Due 2025
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Debt conversion option						$ 177,200,000
Issuance cost attributable to equity component						$ 4,100,000
Convertible senior notes, net	$ 742,235,000	$ 738,847,000

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Long-lived Assets Estimated Useful Lives (Details)	Dec. 31, 2023
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful life	3 years
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful life	4 years
Computers and equipment
Acquired Finite-Lived Intangible Assets [Line Items]
Property and equipment, useful lives	3 years
Furniture and fixtures
Acquired Finite-Lived Intangible Assets [Line Items]
Property and equipment, useful lives	5 years
Capitalized software development costs
Acquired Finite-Lived Intangible Assets [Line Items]
Property and equipment, useful lives	2 years

Marketable Securities - Schedul

Marketable Securities - Schedule of Available-for-sale Marketable Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Marketable Securities [Line Items]
Amortized Cost	$ 2,253,484	$ 1,555,403
Unrealized Gain	2,065	177
Unrealized Losses	(2,990)	(10,239)
Fair Value	2,252,559	1,545,341
Corporate debt securities
Marketable Securities [Line Items]
Amortized Cost	776,323	813,598
Unrealized Gain	770	64
Unrealized Losses	(1,140)	(7,554)
Fair Value	775,953	806,108
Commercial paper
Marketable Securities [Line Items]
Amortized Cost	605,291	357,030
Unrealized Gain	570	64
Unrealized Losses	(75)	(821)
Fair Value	605,786	356,273
U.S. government treasury securities
Marketable Securities [Line Items]
Amortized Cost	460,854	120,977
Unrealized Gain	390	0
Unrealized Losses	(1,399)	(1,099)
Fair Value	459,845	119,878
Certificates of deposit
Marketable Securities [Line Items]
Amortized Cost	264,405	174,080
Unrealized Gain	335	37
Unrealized Losses	(15)	(587)
Fair Value	264,725	173,530
U.S. government agency securities
Marketable Securities [Line Items]
Amortized Cost	146,611	89,718
Unrealized Gain	0	12
Unrealized Losses	(361)	(178)
Fair Value	$ 146,250	$ 89,552

Marketable Securities - Narrati

Marketable Securities - Narrative (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Interest receivable	$ 15,100,000	$ 8,100,000
Interest receivable, allowance for credit loss	$ 0	$ 0

Marketable Securities - Sched_2

Marketable Securities - Schedule of Fair Values of Available-for-Sale Marketable Securities, by Remaining Contractual Maturity (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Due within one year	$ 1,799,542
Due in one year through five years	453,017
Total	$ 2,252,559

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Financial Assets:
Marketable Securities:	$ 2,252,559	$ 1,545,341
Corporate debt securities
Financial Assets:
Marketable Securities:	775,953	806,108
Commercial paper
Financial Assets:
Marketable Securities:	605,786	356,273
Certificates of deposit
Financial Assets:
Marketable Securities:	264,725	173,530
U.S. government treasury securities
Financial Assets:
Marketable Securities:	459,845	119,878
U.S. government agency securities
Financial Assets:
Marketable Securities:	146,250	89,552
Fair Value, Recurring
Financial Assets:
Total financial assets	2,547,924	1,850,736
Fair Value, Recurring | Corporate debt securities
Financial Assets:
Marketable Securities:	775,953	806,108
Fair Value, Recurring | Commercial paper
Financial Assets:
Marketable Securities:	605,786	356,273
Fair Value, Recurring | Certificates of deposit
Financial Assets:
Marketable Securities:	264,725	173,530
Fair Value, Recurring | U.S. government treasury securities
Financial Assets:
Marketable Securities:	459,845	119,878
Fair Value, Recurring | U.S. government agency securities
Financial Assets:
Marketable Securities:	146,250
Fair Value, Recurring | U.S. government agency securities
Financial Assets:
Marketable Securities:		89,552
Fair Value, Recurring | Money market funds
Financial Assets:
Cash equivalents:	240,909	302,902
Fair Value, Recurring | Corporate debt securities
Financial Assets:
Cash equivalents:	484	2,493
Fair Value, Recurring | U.S. government treasury securities
Financial Assets:
Cash equivalents:	53,972
Fair Value, Recurring | Level 1
Financial Assets:
Total financial assets	240,909	302,902
Fair Value, Recurring | Level 1 | Corporate debt securities
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 1 | Commercial paper
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 1 | Certificates of deposit
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 1 | U.S. government treasury securities
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 1 | U.S. government agency securities
Financial Assets:
Marketable Securities:	0
Fair Value, Recurring | Level 1 | U.S. government agency securities
Financial Assets:
Marketable Securities:		0
Fair Value, Recurring | Level 1 | Money market funds
Financial Assets:
Cash equivalents:	240,909	302,902
Fair Value, Recurring | Level 1 | Corporate debt securities
Financial Assets:
Cash equivalents:	0	0
Fair Value, Recurring | Level 1 | U.S. government treasury securities
Financial Assets:
Cash equivalents:	0
Fair Value, Recurring | Level 2
Financial Assets:
Total financial assets	2,307,015	1,547,834
Fair Value, Recurring | Level 2 | Corporate debt securities
Financial Assets:
Marketable Securities:	775,953	806,108
Fair Value, Recurring | Level 2 | Commercial paper
Financial Assets:
Marketable Securities:	605,786	356,273
Fair Value, Recurring | Level 2 | Certificates of deposit
Financial Assets:
Marketable Securities:	264,725	173,530
Fair Value, Recurring | Level 2 | U.S. government treasury securities
Financial Assets:
Marketable Securities:	459,845	119,878
Fair Value, Recurring | Level 2 | U.S. government agency securities
Financial Assets:
Marketable Securities:	146,250
Fair Value, Recurring | Level 2 | U.S. government agency securities
Financial Assets:
Marketable Securities:		89,552
Fair Value, Recurring | Level 2 | Money market funds
Financial Assets:
Cash equivalents:	0	0
Fair Value, Recurring | Level 2 | Corporate debt securities
Financial Assets:
Cash equivalents:	484	2,493
Fair Value, Recurring | Level 2 | U.S. government treasury securities
Financial Assets:
Cash equivalents:	53,972
Fair Value, Recurring | Level 3
Financial Assets:
Total financial assets	0	0
Fair Value, Recurring | Level 3 | Corporate debt securities
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 3 | Commercial paper
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 3 | Certificates of deposit
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 3 | U.S. government treasury securities
Financial Assets:
Marketable Securities:	0	0
Fair Value, Recurring | Level 3 | U.S. government agency securities
Financial Assets:
Marketable Securities:	0
Fair Value, Recurring | Level 3 | U.S. government agency securities
Financial Assets:
Marketable Securities:		0
Fair Value, Recurring | Level 3 | Money market funds
Financial Assets:
Cash equivalents:	0	0
Fair Value, Recurring | Level 3 | Corporate debt securities
Financial Assets:
Cash equivalents:	0	$ 0
Fair Value, Recurring | Level 3 | U.S. government treasury securities
Financial Assets:
Cash equivalents:	$ 0

Property and Equipment, Net - C

Property and Equipment, Net - Components of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 300,740	$ 209,264
Less: accumulated depreciation and amortization	(128,868)	(83,918)
Total property and equipment, net	171,872	125,346
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	35,736	33,376
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	17,202	13,315
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	55,111	27,683
Capitalized software development costs
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 192,691	$ 134,890

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 35.6	$ 27	$ 18.5

Acquisitions, Intangible Asse_3

Acquisitions, Intangible Assets and Goodwill - Additional Information (Details) $ in Thousands	1 Months Ended	12 Months Ended			15 Months Ended
	Apr. 30, 2021 USD ($)	Dec. 31, 2023 USD ($) businessCombination	Dec. 31, 2022 USD ($) businessCombination	Dec. 31, 2021 USD ($)	Dec. 31, 2021 USD ($) businessCombination	Feb. 28, 2021 USD ($)
Acquisition Intangible Assets And Goodwill [Line Items]
Goodwill		$ 352,694	$ 348,277
Intangible amortization expense		$ 8,900	$ 7,600	$ 4,400
Series of Individually Immaterial Business Acquisitions
Acquisition Intangible Assets And Goodwill [Line Items]
Number of purchase agreements | businessCombination		3	4		2
Purchase price allocated to estimated fair value of intangible assets		$ 2,100	$ 8,200	4,300	$ 4,300
Goodwill		$ 3,500	$ 56,600	$ 36,600	$ 36,600
Acquisition in April 2021
Acquisition Intangible Assets And Goodwill [Line Items]
Purchase price allocated to estimated fair value of intangible assets	$ 12,000
Goodwill	204,300
Purchase consideration in cash and stock to acquire business	219,400
Severance costs	1,300
Acquisition in April 2021 | Developed technology
Acquisition Intangible Assets And Goodwill [Line Items]
Purchase price allocated to estimated fair value of intangible assets	$ 8,700
Acquired finite-lived intangible assets, weighted average useful life	3 years
Acquisition in April 2021 | Customer relationships
Acquisition Intangible Assets And Goodwill [Line Items]
Purchase price allocated to estimated fair value of intangible assets	$ 3,300
Acquired finite-lived intangible assets, weighted average useful life	4 years
Acquisition in February 2021
Acquisition Intangible Assets And Goodwill [Line Items]
Purchase price allocated to estimated fair value of intangible assets						$ 1,700
Goodwill						$ 34,300

Acquisitions, Intangible Asse_4

Acquisitions, Intangible Assets and Goodwill - Schedule of Intangibles, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 28,295	$ 27,760
Accumulated Amortization	(18,678)	(11,395)
Net Carrying Amount	9,617	16,365
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	24,995	24,460
Accumulated Amortization	(16,428)	(9,970)
Net Carrying Amount	$ 8,567	$ 14,490
Amortization Period	3 years	3 years
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 3,300	$ 3,300
Accumulated Amortization	(2,250)	(1,425)
Net Carrying Amount	$ 1,050	$ 1,875
Amortization Period	4 years	4 years

Acquisitions, Intangible Asse_5

Acquisitions, Intangible Assets and Goodwill - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Acquisitions, Intangible Assets And Goodwill [Abstract]
2024	$ 6,489
2025	2,597
2026	531
Net Carrying Amount	$ 9,617	$ 16,365

Acquisitions, Intangible Asse_6

Acquisitions, Intangible Assets and Goodwill - Schedule of Changes in Carrying Amount of Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill beginning balance	$ 348,277
2023 Acquisitions	3,540
Foreign currency translation adjustments	877
Goodwill ending balance	$ 352,694

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued cloud hosting and infrastructure expenses	$ 13,783	$ 73,566
Accrued compensation and commissions	61,541	46,736
Other tax liability and sales tax	30,775	25,818
Other accrued expenses	21,532	25,038
Total accrued expenses and other current liabilities	127,631	171,158
Cloud hosting and infrastructure expenses	$ 70,200	$ 12,600

Convertible Senior Notes - Addi

Convertible Senior Notes - Additional Information (Details) $ / shares in Units, shares in Millions		3 Months Ended	12 Months Ended
	Jun. 02, 2020 USD ($) d $ / shares	Dec. 31, 2023 USD ($) d	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)
Debt Instrument [Line Items]
Stockholders' equity		$ 2,025,354,000	$ 2,025,354,000	$ 1,410,505,000	$ 1,041,203,000		$ 957,432,000
Convertible senior notes, net		742,235,000	742,235,000	738,847,000
Accumulated Deficit
Debt Instrument [Line Items]
Stockholders' equity		(153,698,000)	(153,698,000)	(202,266,000)	(152,106,000)		(148,163,000)
Additional Paid-in Capital
Debt Instrument [Line Items]
Stockholders' equity		2,181,267,000	2,181,267,000	1,625,190,000	$ 1,197,136,000		1,103,305,000
Cumulative Effect, Period of Adoption, Adjustment
Debt Instrument [Line Items]
Stockholders' equity							(156,268,000)
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
Debt Instrument [Line Items]
Stockholders' equity							16,802,000
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in Capital
Debt Instrument [Line Items]
Stockholders' equity							$ (173,070,000)
Cumulative Effect, Period of Adoption, Adjustment | ASU No. 2020-06
Debt Instrument [Line Items]
Convertible senior notes, net						$ 156,300,000
Cumulative Effect, Period of Adoption, Adjustment | ASU No. 2020-06 | Accumulated Deficit
Debt Instrument [Line Items]
Stockholders' equity						16,800,000
Cumulative Effect, Period of Adoption, Adjustment | ASU No. 2020-06 | Additional Paid-in Capital
Debt Instrument [Line Items]
Stockholders' equity						$ (173,100,000)
0.125% Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal	$ 747,500,000	$ 747,496,000	747,496,000	747,496,000
Debt instrument, interest rate	0.125%
Debt instrument, net proceeds from sale of notes	$ 730,200,000
Debt instrument, trading days | d		20
Debt instrument, consecutive trading days | d		30
Debt instrument, threshold percentage of conversion price		130%
Debt instrument, principal amount denomination used in conversion		$ 100	100
Debt instrument, convertible carrying amount of equity component	177,200,000
Debt issuance costs	17,300,000
Issuance cost attributable to liability component	$ 13,200,000
Debt instrument, effective interest rate	5.97%
Issuance cost attributable to equity component	$ 4,100,000
Convertible senior notes, net		742,235,000	742,235,000	$ 738,847,000
Debt instrument, estimated fair value		$ 1,050,200,000	$ 1,050,200,000
Initial cap price per share of capped calls (in dollars per share) | $ / shares			$ 151.04
Cost incurred to purchase capped calls			$ 89,600,000
0.125% Convertible Senior Notes Due 2025 | Redemption, On or After June 20, 2023, and Prior to 31st Scheduled Trading Day
Debt Instrument [Line Items]
Debt instrument, trading days | d	20
Debt instrument, consecutive trading days | d	30
Debt instrument redemption price percentage of principal amount redeemed	100%
0.125% Convertible Senior Notes Due 2025 | Class A Common Stock
Debt Instrument [Line Items]
Common stock covered under capped calls (in shares) | shares			8.1
0.125% Convertible Senior Notes Due 2025 | Conversion Preceding March 15, 2025, Scenario One
Debt Instrument [Line Items]
Debt instrument, trading days | d	20
Debt instrument, consecutive trading days | d	30
Debt instrument, threshold percentage of conversion price	130%
0.125% Convertible Senior Notes Due 2025 | Conversion Preceding March 15, 2025, Scenario Two
Debt Instrument [Line Items]
Debt instrument, consecutive trading days | d	10
Debt instrument, convertible, measurement period | d	5
Debt instrument, principal amount denomination used in conversion	$ 1,000
Debt instrument, convertible, threshold maximum percentage of product of last reported sale price of common stock	98%
0.125% Convertible Senior Notes Due 2025 | Conversion, On or After March 15, 2025
Debt Instrument [Line Items]
Debt instrument, consecutive trading days | d	30
Debt instrument, principal amount denomination used in conversion	$ 1,000
Debt instrument, conversion ratio	0.0108338
Debt instrument, conversion price per share (in dollars per share) | $ / shares	$ 92.30

Convertible Senior Notes - Summ

Convertible Senior Notes - Summary of Net Carrying Amount of Liability Component of 2025 Notes (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Jun. 02, 2020
Debt Instrument [Line Items]
Net carrying amount	$ 742,235	$ 738,847
0.125% Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal	747,496	747,496	$ 747,500
Unamortized debt issuance costs	(5,261)	(8,649)
Net carrying amount	$ 742,235	$ 738,847

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense related to 2025 Notes (Details) - 0.125% Convertible Senior Notes Due 2025 - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Contractual interest expense	$ 934	$ 934	$ 934
Amortization of issuance costs	3,388	3,369	3,349
Total	$ 4,322	$ 4,303	$ 4,283

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jun. 02, 2020
Commitments and Contingencies Disclosure [Abstract]
Non-cancelable purchase commitments	$ 485,000,000
Operating lease obligation	347,100,000
Other Commitments [Line Items]
Matching contributions to the 401(k) plan	$ 6,300,000	$ 5,700,000	$ 0
0.125% Convertible Senior Notes Due 2025
Other Commitments [Line Items]
Long-term debt, principal and future interest payments due				$ 749,000,000

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease, renewal term	3 years
Operating lease, termination term	1 year
Rent expense	$ 43.5	$ 34	$ 23.8
Sublease income	0.9	$ 1	$ 1
Operating lease not yet commenced, undiscounted future payments	$ 138.5
Operating lease not yet commenced, term of contract	9 years

Leases - Summary of Components

Leases - Summary of Components of Lease Cost Recognized (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease cost	$ 34,670	$ 25,212	$ 20,198
Short-term lease cost	8,797	8,739	3,609
Operating lease, non-cash lease expense	$ 26,400	$ 21,400	$ 17,200

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information and Non-cash Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Cash paid for amounts included in measurement of lease liabilities	$ 13,273	$ 24,752	$ 20,741
Operating lease assets obtained in exchange for new lease liabilities	$ 61,594	$ 48,404	$ 17,476

Leases - Summary of Maturities

Leases - Summary of Maturities of Lease Liabilities (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Leases [Abstract]
2024	$ 17,995
2025	34,234
2026	31,050
2027	27,747
2028	24,479
Thereafter	73,102
Total lease payments	208,607
Less: imputed interest	(48,505)
Present value of lease liabilities	$ 160,102

Leases - Summary of Weighted Av

Leases - Summary of Weighted Average Remaining Lease Term and Discount Rate (Details)	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Weighted average remaining lease term (years)	6 years 8 months 12 days	6 years 2 months 12 days
Weighted average discount rate	6%	5.12%

Revenue - Schedule of Revenue b

Revenue - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Total	$ 2,128,359	$ 1,675,100	$ 1,028,784
North America
Disaggregation of Revenue [Line Items]
Total	1,487,319	1,200,719	736,218
International
Disaggregation of Revenue [Line Items]
Total	641,040	474,381	292,566
United States
Disaggregation of Revenue [Line Items]
Total	$ 1,411,000	$ 1,134,100	$ 691,800

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Unbilled accounts receivable	$ 61,200	$ 60,000
Accounts charged of accounts receivable deemed uncollectible against the allowance for credit losses	5,500	2,700
Revenue recognized	525,500	374,600	$ 206,600
Deferred contract costs	118,700	88,400
Amortization of deferred contract costs	$ 39,207	$ 28,003	$ 17,866

Revenue - Revenue, Remaining Pe

Revenue - Revenue, Remaining Performance Obligation (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 1,839.4	$ 1,057.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations, expected to recognize period	24 months

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended			37 Months Ended
	Sep. 30, 2019	Dec. 31, 2023 USD ($) right plan class $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) shares	Nov. 30, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock classes | class		2
Number of equity incentive plan | plan		2
Options granted (in shares)		0	0
Proceeds from exercise of stock options | $		$ 20,909	$ 10,001	$ 14,907
Intrinsic value of options exercised | $		565,900	301,600	579,600
Aggregate fair value of options vested | $		12,500	23,900	28,100
Share-based payment arrangement, expense | $		482,300	363,154	163,737
Amounts withheld on behalf of employees for a future purchase | $		$ 0	$ 0	$ 245
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of voting rights entitled to stockholders per share (in dollars per share) | right		1
Common stock, authorized (in shares)		2,000,000,000	2,000,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.00001	$ 0.00001
Common stock, issued (in shares)		305,395,175	293,573,825
Common stock, outstanding (in shares)		305,395,175	293,573,825
Stock issuable upon the exercise of options outstanding (in shares)		22,926	28,557
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of voting rights entitled to stockholders per share (in dollars per share) | right		10
Common stock, number of shares converted (in shares)		2,016,413
Common stock, authorized (in shares)		310,000,000	310,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.00001	$ 0.00001
Common stock, issued (in shares)		25,684,571	25,616,018
Common stock, outstanding (in shares)		25,684,571	25,616,018
Stock issuable upon the exercise of options outstanding (in shares)			18,523,300
Employee stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation cost not yet recognized | $			$ 10,100
Total compensation cost not yet recognized, period for recognition		1 year	7 months 6 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock granted (in shares)					122,224
Award vesting period		4 years
Restricted Stock Units and Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation cost not yet recognized | $		$ 1,187,300	$ 1,151,100
Total compensation cost not yet recognized, period for recognition		2 years 9 months 18 days	2 years 10 months 24 days
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation cost not yet recognized | $		$ 25,100	$ 19,000
Total compensation cost not yet recognized, period for recognition		1 year 3 months 18 days	1 year 4 months 24 days
Award, outstanding (in shares)				0
2012 Equity Incentive Plan | Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issuable upon the exercise of options outstanding (in shares)		12,054,709
2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		73,189,660
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation cost not yet recognized | $		$ 6,800	$ 7,100
Total compensation cost not yet recognized, period for recognition		4 months 24 days	4 months 24 days
Share-based payment arrangement, expiration period	6 months	27 months
Purchase price as percentage of fair market value	85%
Share-based payment arrangement, expense | $		$ 16,000	$ 11,200	$ 7,600
Amounts withheld on behalf of employees for a future purchase | $		$ 6,600	$ 6,000
Employee Stock Purchase Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)		17,481,059
Shares issued (in shares)		517,430	316,875	291,871

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for future issuance (in shares)	116,411,855	109,028,144
Options, RSUs and PSUs outstanding
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for future issuance (in shares)	25,741,136	30,930,540
Shares available for future grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for future issuance (in shares)	73,189,660	63,291,013
Shares subject to the employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for future issuance (in shares)	17,481,059	14,806,591

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Stock Option Activity and Weighted Average Exercise Prices (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Number of Options Outstanding
Beginning balance (in shares)	18,551,857
Options granted (in shares)	0	0
Options exercised (in shares)	(6,455,931)
Options forfeited or expired (in shares)	(18,291)
Ending balance (in shares)	12,077,635	18,551,857
Exercisable (in shares)	12,074,409
Weighted- Average Exercise Price
Beginning balance (in dollars per share)	$ 3.24
Options granted (in dollars per share)	0
Options exercised (in dollars per share)	3.24
Options forfeited or expired (in dollars per share)	5.50
Ending balance (in dollars per share)	3.24	$ 3.24
Exercisable (in dollars per share)	$ 3.23
Weighted- Average Remaining Contractual Life (in Years)
Options outstanding	3 years 4 months 24 days	4 years 4 months 24 days
Exercisable	3 years 4 months 24 days
Aggregate Intrinsic Value (in thousands)
Balance	$ 1,426,912	$ 1,303,464
Exercisable	$ 1,426,607

Stockholders' Equity - Schedu_3

Stockholders' Equity - Schedule of Activity for Unvested RSUs (Details) - Restricted Stock Units, Restricted Stock Awards And Performance Stock Units - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Shares
Unvested and outstanding balance (in shares)	12,378,683
Awarded (in shares)	7,382,006
Vested (in shares)	(4,794,318)
Forfeited/canceled (in shares)	(1,302,870)
Unvested and outstanding balance (in shares)	13,663,501
Weighted-Average Fair Value
Unvested and outstanding balance (in dollars per share)	$ 106.19
Awarded (in dollars per share)	89.09
Vested (in dollars per share)	101.02
Forfeited/canceled (in dollars per share)	102.42
Unvested and outstanding balance (in dollars per share)	$ 99.13
Aggregate Intrinsic Value (in thousands)
Unvested and outstanding balance	$ 1,658,476	$ 909,833

Stockholders' Equity - Schedu_4

Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 482,300	$ 363,154	$ 163,737
Capitalized stock-based compensation	13,597	14,853	9,660
Total stock-based compensation	495,897	378,007	173,397
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	17,578	10,827	4,565
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	313,096	237,120	101,942
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	101,937	76,735	35,035
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 49,689	$ 38,472	$ 22,195

Interest Income and Other Inc_3

Interest Income and Other Income, Net - Schedule of Interest Income and Other Income, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Interest and Other Income [Abstract]
Interest income	$ 103,459	$ 34,931	$ 21,412
Other (loss) income, net	(3,458)	2,229	374
Interest income and other income, net	$ 100,001	$ 37,160	$ 21,786

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Loss Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Domestic	$ 42,811	$ (76,694)	$ (29,617)
Foreign	17,424	38,624	11,195
Income (loss) before provision for income taxes	$ 60,235	$ (38,070)	$ (18,422)

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Taxes Allocated to Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Current, Federal	$ (261)	$ 3,122	$ 232
Deferred, Federal	0	0	0
Federal	(261)	3,122	232
Current, State	2,551	183	44
Deferred, State	0	0	0
State	2,551	183	44
Current, Foreign	10,262	9,179	2,091
Deferred, Foreign	(885)	(394)	(44)
Foreign	9,377	8,785	2,047
Current, Total	12,552	12,484	2,367
Deferred, Total	(885)	(394)	(44)
Total	$ 11,667	$ 12,090	$ 2,323

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 11,667	$ 12,090	$ 2,323
U.S. federal statutory income tax rate	21%	21%	21%
Valuation allowance	$ 321,612	$ 188,817
Change in valuation allowance of deferred tax assets	132,800	40,200
Net operating loss carryforwards for federal tax purposes	$ 148,900	243,400
Percentage of net operating loss carryforwards subjected to taxable income limitation	80%
Net operating loss carryforwards for state tax purposes	$ 206,400	92,000
Unrecognized tax benefits, income tax penalties and interest expense	$ 100	$ 100

Income Taxes - Schedule of Tax

Income Taxes - Schedule of Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense at federal statutory rate	$ 12,650	$ (7,995)	$ (3,868)
Meals and entertainment	1,957	1,717	416
State taxes (net of federal benefit)	1,090	140	18
Net change in valuation allowance	68,770	25,573	62,173
Uncertain tax positions	(94)	3	(728)
U.S. tax costs on international operations	2,037	5,722	1,478
Foreign taxes	1,149	(835)	424
Share based compensation deductions	(69,784)	(1,580)	(57,350)
Return to provision	(3,335)	(1,149)	(193)
U.S. R&D tax credits	(2,973)	(9,467)	0
Other	200	(39)	(47)
Total	$ 11,667	$ 12,090	$ 2,323

Income Taxes - Schedule of Co_2

Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating losses	$ 49,057	$ 54,974
U.S. R&D tax credits	46,639	13,841
Stock-based compensation	47,652	48,872
Section 174 capitalization	181,721	76,625
Lease liability	27,004	18,793
Other	21,593	15,494
Total deferred tax assets	373,666	228,599
Less: valuation allowance	(321,612)	(188,817)
Deferred tax assets, net of valuation allowance	52,054	39,782
Deferred tax liabilities:
Commissions	(29,782)	(22,182)
Right of use asset	(20,916)	(17,151)
Total deferred tax liabilities	(50,698)	(39,333)
Deferred tax assets, net	$ 1,356	$ 449

Income Taxes - Schedule of Chan

Income Taxes - Schedule of Changes in Gross Amount of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance	$ 106	$ 106	$ 532
Increases based on tax positions during the current period	0	0	0
(Decreases) based on tax positions during the current period	(47)	0	(426)
Ending balance	$ 59	$ 106	$ 106

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Basic net income (loss) per share:
Net income (loss)	$ 48,568	$ (50,160)	$ (20,745)
Weighted average shares used in calculating net income (loss) per share, basic (in shares)	324,033	315,410	309,048
Basic net income (loss) per share (in dollars per share)	$ 0.15	$ (0.16)	$ (0.07)
Diluted net income (loss) per share:
Allocation of distributed income (loss) for basic computation	$ 48,568	$ (50,160)	$ (20,745)
Number of shares used in basic calculation (in shares)	324,033	315,410	309,048
Weighted average effect of diluted securities:
Number of shares used in diluted calculation (in shares)	350,292	315,410	309,048
Diluted net income (loss) per share (in dollars per share)	$ 0.14	$ (0.16)	$ (0.07)
Class A Common Stock
Basic net income (loss) per share:
Net income (loss)	$ 44,684	$ (45,163)	$ (16,177)
Weighted average shares used in calculating net income (loss) per share, basic (in shares)	298,116	283,989	240,999
Basic net income (loss) per share (in dollars per share)	$ 0.15	$ (0.16)	$ (0.07)
Diluted net income (loss) per share:
Allocation of distributed income (loss) for basic computation	$ 44,684	$ (45,163)	$ (16,177)
Reallocation of undistributed income (loss) as a result of conversion of Class B to Class A shares	3,884	(4,997)	(4,568)
Allocation of undistributed income (loss)	$ 48,568	$ (50,160)	$ (20,745)
Number of shares used in basic calculation (in shares)	298,116	283,989	240,999
Weighted average effect of diluted securities:
Conversion of Class B to Class A common shares outstanding (in shares)	25,918	31,421	68,049
Shares issuable upon conversion of the convertible senior notes (in shares)	8,098	0	0
Number of shares used in diluted calculation (in shares)	350,292	315,410	309,048
Diluted net income (loss) per share (in dollars per share)	$ 0.14	$ (0.16)	$ (0.07)
Class A Common Stock | Employee stock options
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	14,828	0	0
Class A Common Stock | Shares subject to the employee stock purchase plan
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	15	0	0
Class A Common Stock | RSU
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	2,731	0	0
Class A Common Stock | Restricted Stock
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	586	0	0
Class B Common Stock
Basic net income (loss) per share:
Net income (loss)	$ 3,884	$ (4,997)	$ (4,568)
Weighted average shares used in calculating net income (loss) per share, basic (in shares)	25,918	31,421	68,049
Basic net income (loss) per share (in dollars per share)	$ 0.15	$ (0.16)	$ (0.07)
Diluted net income (loss) per share:
Allocation of distributed income (loss) for basic computation	$ 3,884	$ (4,997)	$ (4,568)
Reallocation of undistributed income (loss) as a result of conversion of Class B to Class A shares	0	0	0
Allocation of undistributed income (loss)	$ 3,884	$ (4,997)	$ (4,568)
Number of shares used in basic calculation (in shares)	25,918	31,421	68,049
Weighted average effect of diluted securities:
Conversion of Class B to Class A common shares outstanding (in shares)	0	0	0
Shares issuable upon conversion of the convertible senior notes (in shares)	0	0	0
Number of shares used in diluted calculation (in shares)	25,918	31,421	68,049
Diluted net income (loss) per share (in dollars per share)	$ 0.15	$ (0.16)	$ (0.07)
Class B Common Stock | Employee stock options
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	0	0	0
Class B Common Stock | Shares subject to the employee stock purchase plan
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	0	0	0
Class B Common Stock | RSU
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	0	0	0
Class B Common Stock | Restricted Stock
Weighted average effect of diluted securities:
Dilutive effect of share-based payment arrangements (in shares)	0	0	0

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in diluted per share calculations (in shares)	2,279	40,465	38,592
Shares subject to outstanding stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in diluted per share calculations (in shares)	2,248	30,931	29,454
Unvested early exercised stock options and restricted shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in diluted per share calculations (in shares)	31	1,120	946
Shares subject to the employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in diluted per share calculations (in shares)	0	316	94
Shares issuable upon conversion of the convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in diluted per share calculations (in shares)	0	8,098	8,098

Uncategorized Items - ddog-2023

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]